<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31780884</article-id>
<article-id pub-id-type="pmc">6861184</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2019.01186</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Soriani</surname>
<given-names>Olivier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/86006/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kourrich</surname>
<given-names>Saïd</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/605655/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Inserm, CNRS, iBV, Université Côte d’Azur</institution>, <addr-line>Nice</addr-line>, <country>France</country></aff>
<aff id="aff2"><sup>2</sup><institution>Département des Sciences Biologiques, Université du Québec à Montréal</institution>, <addr-line>Montréal, QC</addr-line>, <country>Canada</country></aff>
<aff id="aff3"><sup>3</sup><institution>Centre d’Excellence en Recherche sur les Maladies Orphelines – Fondation Courtois, Université du Québec à Montréal</institution>, <addr-line>Montréal, QC</addr-line>, <country>Canada</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Psychiatry, University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Neuroscience, University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Juan J. Canales, University of Tasmania, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Teruo Hayashi, Nishikawa Hospital, Japan; Habibeh Khoshbouei, University of Florida, United States; Maija Dambrova, Latvian Institute of Organic Synthesis (LAS), Latvia</p>
</fn>
<corresp id="c001">*Correspondence: Olivier Soriani, <email>olivier.soriani@unice.fr</email></corresp>
<corresp id="c002">Saïd Kourrich, <email>kourrich.said@uqam.ca</email>; <email>Said.Kourrich@UTSouthwestern.edu</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>13</volume>
<elocation-id>1186</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Soriani and Kourrich.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Soriani and Kourrich</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The sigma-1 receptor (σ1R) is an endoplasmic reticulum (ER)-resident chaperone protein that acts like an inter-organelle signaling modulator. Among its several functions such as ER lipid metabolisms/transports and indirect regulation of genes transcription, one of its most intriguing feature is the ability to regulate the function and trafficking of a variety of functional proteins. To date, and directly relevant to the present review, σ1R has been found to regulate both voltage-gated ion channels (VGICs) belonging to distinct superfamilies (i.e., sodium, Na<sup>+</sup>; potassium, K<sup>+</sup>; and calcium, Ca<sup>2+</sup> channels) and non-voltage-gated ion channels. This regulatory function endows σ1R with a powerful capability to fine tune cells’ electrical activity and calcium homeostasis—a regulatory power that appears to favor cell survival in pathological contexts such as stroke or neurodegenerative diseases. In this review, we present the current state of knowledge on σ1R’s role in the regulation of cellular electrical activity, and how this seemingly adaptive function can shift cell homeostasis and contribute to the development of very distinct chronic pathologies such as psychostimulant abuse and tumor cell growth in cancers.</p>
</abstract>
<kwd-group>
<kwd>sigma-1 receptor</kwd>
<kwd>chaperone protein</kwd>
<kwd>voltage-gated ion channels</kwd>
<kwd>intrinsic excitability</kwd>
<kwd>plasticity</kwd>
<kwd>nervous system disorders</kwd>
<kwd>cancer</kwd>
<kwd>drug addiction</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Office of Extramural Research, National Institutes of Health<named-content content-type="fundref-id">10.13039/100006955</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">Natural Sciences and Engineering Research Council of Canada<named-content content-type="fundref-id">10.13039/501100000038</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="221"></ref-count>
<page-count count="18"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>The sigma-1 receptor (σ1R, a.k.a., Sig-1R), also called sigma non-opioid intracellular receptor 1 and encoded by the gene <italic>SIGMAR1</italic> in humans, is actually not a receptor but a poorly characterized endoplasmic reticulum (ER) chaperone protein. Indeed, upon its discovery, σ1R was originally thought to be a novel opioid receptor (<xref ref-type="bibr" rid="B98">Martin et al., 1976</xref>). However, further pharmacological characterization shows that σ1R does not bind classical opioid ligands but rather binds (+)-benzomorphans (<xref ref-type="bibr" rid="B201">Walker et al., 1990</xref>; see review <xref ref-type="bibr" rid="B166">Schmidt and Kruse, 2019</xref>). σ1R has no known homologs in the eukaryotic genome and is the only known chaperone protein whose activity is regulated by endogenous and synthetic compounds in a clear agonist-antagonist manner (<xref ref-type="bibr" rid="B61">Hayashi and Su, 2007</xref>; <xref ref-type="bibr" rid="B62">Hayashi et al., 2011</xref>). At resting state, σ1R is coupled to BiP (Binding immunoglobulin Protein), another ER-resident chaperone protein. Upon agonist binding and in contrast to antagonist action, σ1R dissociates from BiP and acts as an interorganelle signaling modulator. Importantly, σ1R has been associated with many and diverse chronic diseases ranging from amyotrophic lateral sclerosis to Alzheimer’s disease, cancer and drug addiction (<xref ref-type="bibr" rid="B155">Romieu et al., 2004</xref>; <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>; <xref ref-type="bibr" rid="B86">Kourrich et al., 2012b</xref>; <xref ref-type="bibr" rid="B215">Yasui and Su, 2016</xref>). Among several distinct functions of σ1R that may contribute to these chronic pathologies, its ability to regulate and traffic a variety of functional proteins to the plasma membrane is gaining attraction (<xref ref-type="bibr" rid="B184">Su et al., 2010</xref>, <xref ref-type="bibr" rid="B185">2016</xref>; <xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>; <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>). Specifically, σ1R regulates cellular electrical activity, a mechanism that occurs through physical protein-protein interactions with several VGICs and non-VGICs (<xref ref-type="bibr" rid="B185">Su et al., 2016</xref>; <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>; <xref ref-type="bibr" rid="B166">Schmidt and Kruse, 2019</xref>). In contrast to typical auxiliary ion channel subunits (e.g., Kvβs, Ca<sub><italic>v</italic></sub>β), this ability to associate and regulate functions and surface expression of a myriad of client ion channels from distinct superfamilies (i.e., sodium, Na<sup>+</sup>; potassium, K<sup>+</sup>; and calcium, Ca<sup>2+</sup> channels) posits σ1R as an atypical auxiliary subunit (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; reviewed in <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>). However, the use of <italic>in vitro</italic> model systems, such as cell culture models, <italic>Xenopus</italic> oocytes (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>) and neuroendocrinal tissue (<xref ref-type="bibr" rid="B92">Lupardus et al., 2000</xref>; <xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>) has been a major impediment to our understanding of how σ1R exerts its auxiliary subunit functions <italic>in vivo.</italic> Nonetheless, recent advancement provides evidence that σ1R can bind to ion channels in the brain and that endogenous or exogenous stimuli promotes the formation of these protein complexes, which results in long-lasting changes in cellular electrical activity (<xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>; <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>). The physiological and behavioral consequences of these changes are still largely unknown; however, with the exception of stimulant addiction and cancer, activation of σ1R are typically associated with both physiological and behavioral positive outcomes. Indeed, agonist activation of σ1R ameliorates the negative symptoms in many models of chronic diseases. For example, evidence suggests that activation of σ1R exhibits anti-amnesic effect against Aβ neurotoxicity in a model of Alzheimer’s disease (<xref ref-type="bibr" rid="B73">Jin et al., 2015</xref>); and while σ1R knockout (KO) mice exhibit a depression-like phenotype, σ1 agonists exhibit antidepressant properties (<xref ref-type="bibr" rid="B62">Hayashi et al., 2011</xref>; <xref ref-type="bibr" rid="B203">Wang et al., 2016</xref>). In stark contrast, activation of σ1R promotes the development of tumor growth in cancers (i.e., prostate, colorectal and breast cancers, and leukemia (<xref ref-type="bibr" rid="B147">Renaudo et al., 2007</xref>; <xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>; <xref ref-type="bibr" rid="B54">Gueguinou et al., 2017</xref>; <xref ref-type="bibr" rid="B189">Thomas et al., 2017</xref>) and addiction-relevant behaviors (<xref ref-type="bibr" rid="B78">Katz et al., 2016</xref>).</p>
<p>Stimulant addiction and cancer are very distinct types of severe chronic diseases. In both cases, many factors can trigger or contribute to their development and maintenance. These factors range from external stimuli such as intake or exposure to biological agents to internal factors such as genetic background that may confer vulnerability to the development of the disease. A common adaptation between stimulant addiction and some cancers is that both implicate enduring changes in cellular electrical activity, i.e., cellular intrinsic plasticity (<xref ref-type="bibr" rid="B140">Prevarskaya et al., 2010</xref>; <xref ref-type="bibr" rid="B70">Huang and Jan, 2014</xref>; <xref ref-type="bibr" rid="B126">Pardo and Stuhmer, 2014</xref>; <xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>). The mechanism by which these changes are initiated and their contributions to the development and maintenance of the disease remain elusive. Nonetheless, recent studies revealed that σ1R is a common molecular player involved in the development of cellular electrical plasticity that characterizes both cancer (reviewed in <xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>) and psychostimulant drug addiction (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). We speculate that a reason that explains this opposite negative outcomes of σ1R activity on the development of cancer and psychostimulant abuse lies is the fundamental role of σ1R in cell’s health and survival, and especially, its ability to regulate cellular electrical properties.</p>
<p>As such, in this review, we will present the state of knowledge on σ1R-dependent regulation of ion channels. For the sake of brevity, we will focus on channels that directly contribute to the intrinsic electrical properties of the cell, in both neuronal and non-neuronal cells. Then, we will speculate on how this ability for σ1R to regulate cellular electrical activity, a seemingly adaptive function, can be hijacked and lead to chronic pathological conditions such as cancer and stimulant addiction.</p>
</sec>
<sec id="S2">
<title>σ1R-Dependent Regulation of Ion Channels</title>
<sec id="S2.SS1">
<title>σ1R Is an Atypical Auxiliary Subunit for Ion Channels</title>
<p>σ1R has been proposed to be considered a ligand-regulated auxiliary potassium channel subunit since early 2000s (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>). However, whether σ1R is a <italic>stricto sensu</italic> auxiliary subunit is unclear, as the concept of auxiliary subunits has not been clearly defined. Auxiliary subunits are non-conducting, modulatory components of the multi-protein ion channel complexes that underlie normal neuronal signaling. Typically, auxiliary subunits, including σ1R, are characterized by several features, including (1) directly modulating the biophysical properties of the α pore-forming subunits (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B218">Zhang et al., 2009</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>), (2) participating to the assembly, trafficking and surface expression of the pore-forming subunits (<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>; <xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>), (3) regulating ion currents in ligand-dependent and independent manner (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>), (4) altering pharmacological interactions or bind drugs directly (see reviews <xref ref-type="bibr" rid="B62">Hayashi et al., 2011</xref>; <xref ref-type="bibr" rid="B86">Kourrich et al., 2012b</xref>; <xref ref-type="bibr" rid="B166">Schmidt and Kruse, 2019</xref>), and (5) interacting directly with the pore-forming subunit (<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>, <xref ref-type="bibr" rid="B11">2013</xref>, <xref ref-type="bibr" rid="B9">2014</xref>). However, and in contrast to typical auxiliary subunits, indirect evidence suggest that σ1R is not stably associated with the pore-forming α subunits or present in purified channel complexes, but rather its association with client proteins is dynamic (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). Furthermore, σ1R exhibits specific functional characteristics that are not shared with typical auxiliary subunits. For example, canonical VGIC auxiliary subunits are either cytoplasmic proteins located at the plasmalemma level, i.e., in close proximity of the plasma membrane, or fully integrated in the phospholipidic membrane (<xref ref-type="bibr" rid="B194">Vacher et al., 2008</xref>). Instead, σ1R exhibits a heterogeneous distribution and can be found, in addition to these typical subcellular locations, at the nuclear and associated ER membranes, mitochondrial membrane (<xref ref-type="bibr" rid="B59">Hayashi and Su, 2003a</xref>, <xref ref-type="bibr" rid="B61">2007</xref>; <xref ref-type="bibr" rid="B94">Luty et al., 2010</xref>; <xref ref-type="bibr" rid="B184">Su et al., 2010</xref>; <xref ref-type="bibr" rid="B174">Shioda et al., 2012</xref>) and potentially in extracellular space (<xref ref-type="bibr" rid="B59">Hayashi and Su, 2003a</xref>). Furthermore, while emerging evidence suggest that some channel family-specific auxiliary subunits have the ability to regulate ion channels from other superfamilies, such as the Na<sup>+</sup> channel auxiliary subunits Na<sub><italic>v</italic></sub>β modulating voltage-gated K<sup>+</sup> channels (<xref ref-type="bibr" rid="B97">Marionneau et al., 2012</xref>; <xref ref-type="bibr" rid="B20">Calhoun and Isom, 2014</xref>), this feature is extended and even exacerbated in σ1R. In particular, σ1R regulates via direct protein-protein interactions the functions of all VGIC superfamilies (i.e., Na<sup>+</sup>, Ca<sup>2+</sup>, and K<sup>+</sup> families) and classes (i.e., ligand-gated ion channels, e.g., NMDA receptors, NMDARs; and G protein-coupled receptors, e.g., dopamine receptors, DARs) (reviewed in <xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>; <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>; <xref ref-type="bibr" rid="B179">Soriani and Rapetti-Mauss, 2017</xref>; <xref ref-type="bibr" rid="B166">Schmidt and Kruse, 2019</xref>). This unique characteristic positions σ1R as a powerful regulator of various cellular functions and neuronal excitability.</p>
</sec>
<sec id="S2.SS2">
<title>σ1R-Dependent Regulation of VGICs</title>
<p>A feature that differentiates neuronal from non-neuronal cells is their excitability and their unique shape, which together endow neurons with the capability to receive, integrate and propagate the information within brain circuits. As such, this section will refer mainly to voltage-gated Na<sup>+</sup>, Ca<sup>2+</sup>, and K<sup>+</sup> channels, i.e., the non-synaptic factors that are responsible for the generation and propagation of action potentials (<xref ref-type="bibr" rid="B66">Hille, 2001</xref>). This process is made possible thanks to a tight control of ion channels’ maturation, their delivery at the plasma membrane and their functional regulation. While the role of common K<sup>+</sup> channel auxiliary subunits (e.g., Kvβs and KChips) is these processes are extensively studied (<xref ref-type="bibr" rid="B96">Maffie and Rudy, 2008</xref>; <xref ref-type="bibr" rid="B194">Vacher et al., 2008</xref>), the regulatory power of σ1R, emerging as a new but atypical auxiliary subunit (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; reviewed in <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>), is scarcely understood. On that matter, we know today that σ1R regulates neuronal intrinsic excitability via trafficking of VGICs (particularly Kv channels) to the plasma membrane (reviewed in <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>), a function that operate in ligand-dependent and -independent manner. Though σ1R regulates the trafficking of VGICs from the ER to the cell surface, the mechanism remains unclear. Interestingly, σ1R possesses a double-arginine ER retention signal (RR) at the N-terminus (<xref ref-type="bibr" rid="B60">Hayashi and Su, 2003b</xref>). Because arginine-based intracellular retention signals are used to regulate assembly and surface transport of several multimeric complexes including ion channels (<xref ref-type="bibr" rid="B169">Scott et al., 2003</xref>; <xref ref-type="bibr" rid="B48">Gassmann et al., 2005</xref>; <xref ref-type="bibr" rid="B137">Phartiyal et al., 2008</xref>), it is tempting to speculate that such a mechanism may also apply to the regulation of VGICs by σ1R.</p>
<p>Modulation of neuronal intrinsic excitability is a critical mechanism that controls a plethora of physiological and cognitive functions. These functions range from the generation and propagation of information within brain circuits to the control of the capability of neurons to undergo synaptic plasticity, and thereby lead to lasting changes in behavior such as learning and memory. Yet, the regulatory power of σ1R remains elusive, partly because σ1R’s regulatory functions have been investigated using mainly heterologous cell culture systems (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>; reviewed in <xref ref-type="bibr" rid="B82">Kourrich, 2017</xref>). Further, the use of promiscuous ligands when investigating the regulatory functions of σ1R has so far prevented reaching molecular specificity.</p>
<p>σ1R-dependent regulation of VGICs can be mediated through direct protein-protein interactions or indirectly through G proteins. As such, σ1R has the capability to regulate neuronal intrinsic excitability and exert a strong influence on the ability for a neuron to generate action potentials in response to synaptic inputs, fine tune firing frequency, and conduct action potentials along the axon. This section summarizes evidence supporting σ1R regulations of VGICs and its resulting effects on their functions (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1</xref>), which appear to be influenced by several factors, including the physiological milieu, brain regions, experimental preparations and neuronal types. However, a critical factor that exerts a strong influence on functional outcomes is σ1R’s conformational and oligomerization states, which appear to be dependent on the class of ligands used (<xref ref-type="bibr" rid="B52">Gromek et al., 2014</xref>; <xref ref-type="bibr" rid="B107">Mishra et al., 2015</xref>; reviewed in <xref ref-type="bibr" rid="B28">Chu and Ruoho, 2016</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Summary of σ1R activation effects on VGICs.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Functional effects on currents<sup>∗</sup></bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Mode of activation</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Experimental system</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Mechanism/Evidence</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<bold>Ca<sup>2+</sup> currents</bold>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓N, L, P/Q and R-type</td>
<td align="left" colspan="1" rowspan="1" valign="top">Haloperidol, ibogaine, (+)-pentazocine, DTG</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parasympathic intracardiac neurons; superior cervical ganglia (cell culture)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/2nd messenger systems and G proteins not required</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B216">Zhang and Cuevas, 2002</xref>
<sup>∗∗</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓L-type</td>
<td align="left" colspan="1" rowspan="1" valign="top">(+)-SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal ganglion cells (cell culture)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/co-IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B188">Tchedre et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<bold>Na<sup>+</sup> currents</bold>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓Nav1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">(+)-pentazocine, (+)-SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell lines (HEK293, COS-7), Cardiac myocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/2nd messenger systems and G proteins not required</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B74">Johannessen et al., 2009</xref>; <xref ref-type="bibr" rid="B46">Fontanilla et al., 2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">tsA 201 cells, breast cancer cell lines (MDA-MB-231)</td>
<td align="left" colspan="1" rowspan="1" valign="top">AFM</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(+)-pentazocine</td>
<td align="left" colspan="1" rowspan="1" valign="top">intracardiac ganglion neurons (isolated neurons from neonatal rats)</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B218">Zhang et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<bold>K<sup>+</sup> currents</bold>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓<italic>I</italic><sub><italic>A</italic></sub></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pentazocine, SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurohypophysial terminals (pituitary gland slices)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/2nd messenger systems and G proteins not required</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B92">Lupardus et al., 2000</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">JO 1784, (+)-pentazocine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroendocrine pituitary cell culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">Indirect/Gs protein required</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B177">Soriani et al., 1999a</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓<italic>I</italic><sub><italic>A</italic></sub> (Kv1.4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Xenopus</italic> oocytes; rat posterior pituitary gland</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/co-IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓<italic>I</italic><sub><italic>K(DR)</italic>,</sub>
<italic>I</italic><sub><italic>BK</italic></sub></td>
<td align="left" colspan="1" rowspan="1" valign="top">DTG, (+)-pentazocine, ibogaine,</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parasympathic intracardiac neurons (cell culture), neuroendocrine pituitary cell culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/2nd messenger systems and G proteins not required</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B180">Soriani et al., 1998</xref>; <xref ref-type="bibr" rid="B217">Zhang and Cuevas, 2005</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓<italic>I</italic><sub><italic>M</italic></sub></td>
<td align="left" colspan="1" rowspan="1" valign="top">(+)-pentazocine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary frog neuroendocrine pituitary cell culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">Indirect/Gs protein required</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B178">Soriani et al., 1999b</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑Kv1.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>In vitro</italic> and <italic>in vivo</italic> cocaine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain tissue (NAc and PFC); cell lines (NG108-15, Neuro2A, HEK293T)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/co-IP</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓Kv1.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">±σ1R expression</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Xenopus</italic> oocytes; HEK 293 cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/co-IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(+)-pentazocine, igmesine, DTG</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jurkat cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B148">Renaudo et al., 2004</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓Kv1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Xenopus</italic> oocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">G protein-independent</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑Kv2.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyproheptadine, PRE-084</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse cortical neurons, HEK293T cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gi protein-dependent</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B63">He et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓<italic>I</italic><sub><italic>hERG</italic></sub> (Kv11.1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Igmesine</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Xenopus</italic> oocytes; HEK293; human K562; myeloid leukemia cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/co-IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">none</td>
<td align="left" colspan="1" rowspan="1" valign="top">HCT116 human; colorectal cancer cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/FRET/Proximity Ligation Assay</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HEK293</td>
<td align="left" colspan="1" rowspan="1" valign="top">Direct/FRET, AFM</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓Kir2.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">SKF10047</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse embryonic fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B210">Wong et al., 2016</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup>∗</sup>All effects on ion channels’ current were obtained with electrophysiological recordings. <sup>∗∗</sup>Rank order potency of various σR ligands suggest these effects may be through σ2R. AFM, atomic force microscopy; co-IP, coimmunoprecipitation; <italic>I</italic><sub><italic>A</italic></sub>, A-type K<sup>+</sup> current; <italic>I</italic><sub><italic>BK</italic></sub>, large-conductance Ca<sup>2 +</sup>-activated K<sup>+</sup> current; <italic>I</italic><sub><italic>hERG</italic></sub>, human ether-à-gogo K<sup>+</sup> current; <italic>I</italic><sub><italic>K(DR)</italic></sub>, delayed outwardly rectifying K<sup>+</sup> current; NAc, nucleus accumbens; nd, not determined; PFC, prefrontal cortex.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic diagram illustrating direct σ1R-dependent regulation of ion channels in neuronal and cancer cells. <bold>(A)</bold> Upon ligand stimulation [e.g., cocaine, (+)-pentazocine, PRE-084], σ1R dissociates from binding immunoglobulin protein (BiP), another endoplasmic reticulum (ER) chaperone protein, and then translocates from the mitochondrion-associated ER membrane (MAM, interface between mitochondrion and ER) to the ER and plasmalemma. Acting as an interorganelle signaling modulator, σ1R regulates a variety of functional proteins, both directly and indirectly. Here are represented only the regulations mediated by direct interaction with the targets. Pointed and flathead arrows indicate positive and negative regulations respectively. Unbroken and dashed lines indicate direct and indirect evidence for σ1R:Ion channels physical interactions. On the one hand, σ1R upregulates ion channel expression at the plasma membrane either through the regulation of subunit trafficking activity (hERG) (<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>) or a mechanism that remains unidentified (Kv1.2) (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). σ1R activation by (+)-SKF 10,047 enhances binding with NMDARs, a mechanism that may play a role in NMDAR subunits trafficking to the cell surface (<xref ref-type="bibr" rid="B11">Balasuriya et al., 2013</xref>; <xref ref-type="bibr" rid="B122">Pabba et al., 2014</xref>). On the other hand, σ1R inhibits ion currents through modulation of target’s biophysical properties (Kv1.3, Kv1.4) (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>) and likely trafficking mechanisms (Na<sub><italic>v</italic></sub>1.5) (<xref ref-type="bibr" rid="B74">Johannessen et al., 2009</xref>; <xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>). This can occur through both ligand-independent (Kv1.3, Kv1.4, Kv1.5) (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>) and ligand-dependent mechanisms (Kv1.4, Kv1.5) (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>). σ1R can both enhance (<xref ref-type="bibr" rid="B162">Sabeti et al., 2007</xref>) and inhibit (<xref ref-type="bibr" rid="B188">Tchedre et al., 2008</xref>) L-type Ca<sup>2+</sup> currents. Adapted from <xref ref-type="bibr" rid="B82">Kourrich (2017)</xref>. <bold>(B)</bold> By shaping cancer cell electrical signature, σ1R participates to cancer hallmarks. (1) σ1R functionally modulates VRCC and K<sup>+</sup> channels restricting cell sensitivity to AVD without altering cell cycle progression; (2) σ1R binds SK3 channel and promotes the formation of SK3:ORAI1 complexes within cholesterol-rich nanodomains responsible for increased Ca<sup>2+</sup> influx and migration potency; and (3) σ1R dynamically associates hERG channels to integrins upon cell stimulation by ECM triggering motility, angiogenesis and invasiveness.</p>
</caption>
<graphic xlink:href="fnins-13-01186-g001"></graphic>
</fig>
<sec id="S2.SS2.SSS1">
<title>Voltage-Gated Ca<sup>2+</sup> Channels</title>
<p>Ca<sup>2+</sup> influx through voltage-gated Ca<sup>2+</sup> channels at the synapse play a key role in both fast synaptic transmission, i.e., allows the initiation of a mechanism necessary for neurotransmitter release, and in the regulation of intracellular signaling, thereby initiating slow and lasting changes in neuronal activity (<xref ref-type="bibr" rid="B38">Dolphin, 2009</xref>; <xref ref-type="bibr" rid="B23">Catterall, 2010</xref>). σ1R modulates intracellular Ca<sup>2+</sup> concentration through both the regulation of membrane voltage-gated Ca<sup>2+</sup> channels (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1A</xref>) and Ca<sup>2+</sup> mobilization from endoplasmic stores (<xref ref-type="bibr" rid="B57">Hayashi et al., 2000</xref>; <xref ref-type="bibr" rid="B58">Hayashi and Su, 2001</xref>; for reviews see <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B45">Fishback et al., 2010</xref>; <xref ref-type="bibr" rid="B184">Su et al., 2010</xref>).</p>
<p>Although the subtype of σ receptors, σ1R or σ2R, was not identified yet, early indirect evidence linked σ receptors to modulations of Ca<sup>2+</sup> channels’ functions (<xref ref-type="bibr" rid="B156">Rothman et al., 1991</xref>; <xref ref-type="bibr" rid="B29">Church and Fletcher, 1995</xref>; <xref ref-type="bibr" rid="B16">Brent et al., 1997</xref>). These studies, using binding, pharmacological and electrophysiological assays, showed that various σ receptor ligands inhibit intracellular Ca<sup>2+</sup> dynamics. Although high concentrations of σ receptors’ ligands used in these studies did not exclude unspecific off-target effects, such as direct actions of ligands on Ca<sup>2+</sup> channels rather than on σ receptors, the discovery of highly selective toxins for specific voltage-gated Ca<sup>2+</sup> channels provided evidence that σ receptors associate with and regulate voltage-gated Ca<sup>2+</sup> channels (<xref ref-type="bibr" rid="B16">Brent et al., 1997</xref>). Consistent with these findings, Cuevas and colleagues showed that σ receptor agonists, although the rank order potency of these ligands suggests these effects may be through σ2 rather than σ1 receptors, alters several Ca<sup>2+</sup> channels’ biophysical properties on intracardiac ganglionic neurons (N-, L-, P/Q-, and R-type Ca<sup>2+</sup> channels) (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1A</xref>), all consistent with inhibition of Ca<sup>2+</sup> influx. Interestingly, the mechanism through which σ receptors agonists exerted their inhibitory effects were independent on second messenger systems and G proteins (<xref ref-type="bibr" rid="B216">Zhang and Cuevas, 2002</xref>), suggesting that the putative σ receptor exerts its inhibitory action through protein-protein interactions with its client ion channel. To date, only the L-type voltage-gated Ca<sup>2+</sup> channel has been identified as a direct target for σ1R (<xref ref-type="bibr" rid="B188">Tchedre et al., 2008</xref>). In particular, using both specific σ1R receptor ligands and co-immunoprecipitation assays, <xref ref-type="bibr" rid="B188">Tchedre et al. (2008)</xref> showed that σ1R activation with (+)-SKF 10,047 inhibits Ca<sup>2+</sup> currents—an effect that is prevented by σ1R antagonist BD 1047 and that appears to be mediated via direct σ1R binding to L-type voltage-gated Ca<sup>2+</sup> channel (<xref ref-type="bibr" rid="B188">Tchedre et al., 2008</xref>) (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1A</xref>). In contrast, pregnenolone sulfate activation of σ1R increases L-type Ca<sup>2+</sup> currents in the CA1 region of the hippocampus—a mechanism that promotes the induction of synaptic plasticity (i.e., long-term potentiation) (<xref ref-type="bibr" rid="B162">Sabeti et al., 2007</xref>). These findings suggest that the effects of σ1R ligands differ between preparations and/or regions of the nervous system. These discrepancies may also be due to the presence and type of ligands, which control σ1R’s conformational and oligomerization states (monomeric vs. oligomeric) (<xref ref-type="bibr" rid="B52">Gromek et al., 2014</xref>; <xref ref-type="bibr" rid="B107">Mishra et al., 2015</xref>; reviewed in <xref ref-type="bibr" rid="B28">Chu and Ruoho, 2016</xref>).</p>
<p>Besides voltage-gated Ca<sup>2+</sup>channels, σ1R also regulates non-voltage-gated Ca<sup>2+</sup>-permeable channels via protein-protein interactions, including IP3 receptors at the ER level (<xref ref-type="bibr" rid="B61">Hayashi and Su, 2007</xref>; reviewed in <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B45">Fishback et al., 2010</xref>; <xref ref-type="bibr" rid="B184">Su et al., 2010</xref>), and plasma membrane acid-sensing ion channels 1a (ASIC1a) (<xref ref-type="bibr" rid="B65">Herrera et al., 2008</xref>; <xref ref-type="bibr" rid="B22">Carnally et al., 2010</xref>).</p>
</sec>
<sec id="S2.SS2.SSS2">
<title>Voltage-Gated Na<sup>+</sup> Channels</title>
<p>To date, and in contrast to bidirectional action of σ1R on Ca<sup>2+</sup> currents, σ1R ligands exert inhibitory actions on Na<sup>+</sup> currents (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figures 1A,B</xref>). <xref ref-type="bibr" rid="B218">Zhang et al. (2009)</xref> reported that σ1R ligand activation decreases neuronal intrinsic excitability, an effect mediated by hyperpolarization of Na<sup>+</sup> channels’ steady-state inactivation and characterized by a decreased ability to initiate neuronal firing. In contrast, other studies found that σ1R ligand activation in various cell preparations [e.g., mouse cardiac myocytes, COS-7 and human embryonic kidney cells (HEK293)] inhibits Na<sub><italic>v</italic></sub>1.5-mediated currents without altering channel’s biophysical properties (<xref ref-type="bibr" rid="B46">Fontanilla et al., 2009</xref>; <xref ref-type="bibr" rid="B74">Johannessen et al., 2009</xref>). Since these effects were mediated in the absence of GTP or ATP, this mechanism is thought to be independent of G-proteins and protein kinases (<xref ref-type="bibr" rid="B74">Johannessen et al., 2009</xref>), suggesting direct interaction between σ1R and Na<sub><italic>v</italic></sub>1.5. Indeed, studies using atomic force microscopy (AFM) imaging provided direct evidence for σ1R-Na<sub><italic>v</italic></sub>1.5 protein-protein association (<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>). However, since only 6% of the two proteins appears to interact, σ1R may be involved in Na<sub><italic>v</italic></sub>1.5 trafficking or maturation, a process that requires association-dissociation with Na<sub><italic>v</italic></sub>1.5. Strikingly, these authors also observed that the molecular silencing of σ1R in a breast cancer line reduced Na<sub><italic>v</italic></sub>1.5 current density and that (+)-pentazocine reduced interaction between σ1R and Na<sub><italic>v</italic></sub>1.5 alpha subunits (<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>). Taken together, these results suggest that σ1R increases the number of channels at the plasma membrane, while σ1R ligands exerts inhibitory action through either decreasing Na<sup>+</sup> current or rendering Na<sup>+</sup> channels unavailable.</p>
</sec>
<sec id="S2.SS2.SSS3">
<title>Voltage-Gated K<sup>+</sup> Channels</title>
<p>Early seminal studies found that the σ1R modulates K<sup>+</sup> currents (<xref ref-type="bibr" rid="B12">Bartschat and Blaustein, 1988</xref>; <xref ref-type="bibr" rid="B80">Kennedy and Henderson, 1990</xref>; <xref ref-type="bibr" rid="B211">Wu et al., 1991</xref>). However, results from <xref ref-type="bibr" rid="B112">Morio et al. (1994)</xref> were likely the first to suggest that this modulatory ability may involve direct interactions with K<sup>+</sup> channels. Specifically, authors showed that σ1R ligand activation inhibits outward K<sup>+</sup> conductance in GTP- and second messenger systems-independent manner (e.g., protein kinase A, PKA; and protein kinase C, PKC) (<xref ref-type="bibr" rid="B112">Morio et al., 1994</xref>). Later studies conducted in neuronal cells [i.e., rodent neurohypophysial nerve terminals (<xref ref-type="bibr" rid="B92">Lupardus et al., 2000</xref>) and parasympathic intracardiac neurons (<xref ref-type="bibr" rid="B217">Zhang and Cuevas, 2005</xref>)] provided additional evidence that σ1R agonist activation inhibits various K<sup>+</sup> currents independently of ATP- and GTP-dependent processes, including delayed outward rectifier K<sup>+</sup> current (<italic>I</italic><sub><italic>KDR</italic></sub>), large conductance Ca<sup>2+</sup>-sensitive K<sup>+</sup> channels (<italic>I</italic><sub><italic>BK</italic></sub>) and M-current (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure 1A</xref>). By contrast, in frog pituitary melanotroph cells (neuroendocrine cells), sigma ligands including Igmesine and (+)-pentazocine, increase action potential firing through a Gs-dependent inhibition of voltage-dependent K<sup>+</sup> currents. Indeed, sigma ligands decrease <italic>I</italic><sub><italic>KDR</italic></sub> current density and accelerate <italic>I</italic><sub><italic>A</italic></sub> inactivation, together with a leftward shift in voltage-dependent inactivation curve (<xref ref-type="bibr" rid="B180">Soriani et al., 1998</xref>, <xref ref-type="bibr" rid="B177">1999a</xref>). Moreover, (+)-pentazocine was shown to accelerate deactivation rate of the M-current, together with rightward shift in the steady-state activation curve (<xref ref-type="bibr" rid="B178">Soriani et al., 1999b</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>To date, several K<sup>+</sup> channels have been found to be regulated by direct σ1R binding (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figures 1A,B</xref>). Interestingly, this regulatory mechanism can occur through σ1R ligand-dependent or -independent mechanisms. Specifically, studies in <italic>Xenopus</italic> oocytes showed that in the absence of ligand, σ1R accelerates Kv1.4 inactivation time constant—an effect that is dependent on σ1R:Kv1.4 ratio—and similar to that observed with Kv1.3 (<xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>). Instead, application of the σ1R agonist SKF10,047 dramatically reduces outward K<sup>+</sup> current of both Kv1.4 and Kv1.5 by ∼75% (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>). Using both <italic>Xenopus</italic> oocytes and neuroendocrine tissue (i.e., posterior pituitary gland), <xref ref-type="bibr" rid="B7">Aydar et al. (2002)</xref> found that this modulatory effect is mediated through σ1R-Kv1.4 protein-protein interactions, which is also further supported by co-localization studies in CHO-K1 cells (<xref ref-type="bibr" rid="B102">Mavlyutov and Ruoho, 2007</xref>).</p>
<p>Human Ether-a-go-go Related Gene (hERG, also named Kv11.1), another member of the voltage-dependent K<sup>+</sup> channel family, also directly interacts with σ1R, as shown by co-immunoprecipitation, fluorescence resonance energy transfer (FRET) and AFM experiments (<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>; <xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>). hERG is mainly expressed in the heart, brain or neuroendocrine tissues where it regulates firing pattern (<xref ref-type="bibr" rid="B196">Vandenberg et al., 2012</xref>). hERG is also aberrantly expressed in leukemias and epithelial cancers and has been clearly involved in disease progression (<xref ref-type="bibr" rid="B13">Becchetti et al., 2019</xref>). In HEK cells, σ1R increases maturation rate and channel stability at the plasma membrane. Accordingly, σ1R molecular silencing reduces current density in colorectal cancer (CRC) and leukemia cell lines, demonstrating that, in the absence of any ligand, σ1R stimulates hERG function (<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>, <xref ref-type="bibr" rid="B31">2013</xref>, <xref ref-type="bibr" rid="B33">2016</xref>), a result which is in contrast with those obtained with Kv1.5 channels in <italic>Xenopus</italic> oocytes where σ1R behaves as a negative modulator (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>). Noteworthy, cell incubation with the σ1R agonist igmesine (JO1784) produces the same effect as protein silencing on hERG current density. In contrast to Na<sub><italic>v</italic></sub>1.5/σ1R interaction, hERG/σ1R was resistant to (+)-pentazocine (<xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>). Interestingly, σ1R is required for the fast recruitment of hERG by integrins at the plasma membrane following cancer cell activation by the extra cellular matrix (ECM), suggesting that σ1R dynamically regulates ion channel activity depending on external stimulations (<xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>).</p>
<p>While most of previous studies were performed in heterologous systems (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>) or in neuroendocrinal tissue <italic>in vitro</italic> (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>), σ1R-dependent modulation of Kv currents has also been shown to occur in the brain <italic>in vivo</italic> (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>). Here, authors found that σ1R forms a complex with Kv1.2 channels in the nucleus accumbens (NAc), a critical hub of motivational neural networks, and the prefrontal cortex (PFC), a brain region involved in decisional processes. These protein complexes undergo enduring cocaine-driven upregulation in NAc inhibitory medium spiny projection neurons (MSNs) and thereby lead to persistent decrease in neuronal intrinsic excitability that lasts beyond the detoxification period—a neuroadaptation that contributes to behavioral response to cocaine (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>). Cocaine-induced increase in σ1R-Kv1.2 complexes, a mechanism that promotes Kv1.2 trafficking to the plasma membrane, was also evidence in heterologous expression systems (NG108-15, Neuro2A and HEK293T cell lines), suggesting that the association between Kv1.2 and σ1R is a conserved mechanism (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). In sum, these studies demonstrate that the ability for σ1R to bind and regulate Kv functions and surface expression levels can be hijacked by external stimuli and lead to sustained maladaptive changes in cells’ electrical signature and contribute to nervous system disorders. Interestingly, a recent study confirming basal interaction between σ1R and Kv1.2 in HEK293T cells also found that this mechanism influences Kv1.2’s biophysical properties such as bimodal activation gating (<xref ref-type="bibr" rid="B1">Abraham et al., 2019</xref>).</p>
<p>Taken together, the σ1R associates with several K<sup>+</sup> channels, and these associations can modulate K<sup>+</sup> channels functions (<xref ref-type="bibr" rid="B7">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B81">Kinoshita et al., 2012</xref>) or regulate subunits maturation and trafficking to the plasma membrane (<xref ref-type="bibr" rid="B32">Crottès et al., 2011</xref>; <xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>).</p>
</sec>
<sec id="S2.SS2.SSS4">
<title>Non-voltage Gated Channels</title>
<p>σ1R not only binds voltage-gated channels. For example, AFM studies revealed that the chaperone also forms aggregates with Asic1a and NMDA receptors (<xref ref-type="bibr" rid="B22">Carnally et al., 2010</xref>; <xref ref-type="bibr" rid="B11">Balasuriya et al., 2013</xref>) and a recent work indicated a functional coupling with Kir2.1 channels (<xref ref-type="bibr" rid="B210">Wong et al., 2016</xref>). Last, in breast cancer cells, σ1R is tightly associated to SK3 (KCNN3) and promotes the functional association of the K<sup>+</sup> channel to Orai1 Ca<sup>2+</sup> channels. Interestingly, the coupling between the two channels is destroyed either in the absence of σ1R (molecular silencing) or by incubation with the sigma ligand igmesine (<xref ref-type="bibr" rid="B54">Gueguinou et al., 2017</xref>).</p>
</sec>
</sec>
</sec>
<sec id="S3">
<title>σ1R:Ion Channels in Chronic Diseases: Stimulant Addiction and Cancer</title>
<p>σ1R is associated with distinct types of chronic diseases such as nervous system disorders, including Alzheimer’s disease, multiple sclerosis, depression, stimulant addiction, and cancer types such as colorectal, lung, prostate, breast cancers and leukemia (<xref ref-type="bibr" rid="B148">Renaudo et al., 2004</xref>, <xref ref-type="bibr" rid="B147">2007</xref>; <xref ref-type="bibr" rid="B155">Romieu et al., 2004</xref>; <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>; <xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B8">Aydar et al., 2016</xref>; <xref ref-type="bibr" rid="B189">Thomas et al., 2017</xref>). Nonetheless, the mechanism through which σ1R operates in such diseases remains elusive. Over the last few years, cancer research has accumulated evidence suggesting that σ1R, particularly <italic>via</italic> modulation of voltage-gated K<sup>+</sup> channels, may contribute to various cellular functions that result in tumor growth (<xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>). Regarding stimulant addiction, another chronic disease, recent discoveries identified novel and unconventional σ1R-driven mechanisms that contribute to the development and likely the maintenance of psychostimulant abuse, some of which implicate enduring changes in neuronal intrinsic excitability (<xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). In addition to cancer and stimulant addiction, these findings extend the putative role for σ1R-driven intrinsic plasticity to other chronic neurological and neuropsychiatric disorders where both changes in intrinsic excitability and σ1R are engaged, e.g., Alzheimer’s disease, multiple sclerosis, and neuropathic pain. For the sake of brevity, this section will focus on stimulant addiction and cancer, two distinct type of chronic diseases whose contributing mechanisms implicate enduring changes in σ1R-driven trafficking of VGICs.</p>
<sec id="S3.SS1">
<title>Stimulant Addiction</title>
<p>Drugs of abuse, and especially psychostimulant drugs, enhance dopamine (DA) and/or other monoamines (e.g., serotonin, 5-HT; and noradrenaline, NA) signaling in brain reward circuits (<xref ref-type="bibr" rid="B36">Di Chiara and Imperato, 1988</xref>), including in the NAc shell and the prefrontal cortex. Overactivation of DA receptors triggers second messengers’ systems, involving protein kinases and phosphatases, leads to enduring changes in neuronal activity. To date, while the effects of psychostimulant drugs on glutamate synaptic strength has been extensively studied (<xref ref-type="bibr" rid="B207">Wolf, 2010</xref>, <xref ref-type="bibr" rid="B208">2016</xref>; <xref ref-type="bibr" rid="B93">Luscher and Malenka, 2011</xref>; <xref ref-type="bibr" rid="B209">Wolf and Tseng, 2012</xref>), little is known about how they alter neuronal firing (<xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>). While σ1R has long been associated with addiction to psychostimulant drugs [e.g., cocaine and methamphetamine (METH)] and alcohol (<xref ref-type="bibr" rid="B155">Romieu et al., 2004</xref>; <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>; <xref ref-type="bibr" rid="B86">Kourrich et al., 2012b</xref>; <xref ref-type="bibr" rid="B215">Yasui and Su, 2016</xref>), it is unclear whether and how σ1R contributes to these changes. Although several scenario have been proposed, a prominent hypothesis originates from σ1R’s ability to modulate monoaminergic systems, and thereby neuronal intrinsic excitability (<xref ref-type="bibr" rid="B118">Nichols and Nichols, 2008</xref>; <xref ref-type="bibr" rid="B4">Andrade, 2011</xref>; <xref ref-type="bibr" rid="B30">Ciranna and Catania, 2014</xref>). In this section, for the sake of brevity and due to the state of knowledge, we review evidence linking σ1R-driven plasticity of neuronal intrinsic excitability and addictive processes triggered by exposure to psychostimulant drugs; and when possible, we will discuss mechanisms by which monoamine signaling systems may also be involved.</p>
<p>Regarding psychostimulant drugs, although σR subtypes (σ1R vs. σ2R) were not identified yet, early studies from Ujike and colleagues found that σRs antagonists (BMY-14802, rimcazole or SR-31742A) block the development of psychomotor sensitization to cocaine and METH (<xref ref-type="bibr" rid="B190">Ujike et al., 1992a</xref>,<xref ref-type="bibr" rid="B191">b</xref>,<xref ref-type="bibr" rid="B192">c</xref>, <xref ref-type="bibr" rid="B193">1996</xref>). Today, we know that this inhibitory effect of σR antagonists, and especially σ1R, extends to other addiction-relevant behaviors, including conditioned-place preference and drug self-administration, a model that closely mimic human condition (reviewed in <xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>; <xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>, <xref ref-type="bibr" rid="B78">2016</xref>). While the conventional mechanism of action of psychostimulant drugs is to enhance DA (and other monoamines) signaling in the brain, accumulating evidence suggest that in addition to this mechanism, σ1R can exert its pro-addictive functions independently of DA signaling. An intriguing candidate mechanism originate from early studies that demonstrate that psychostimulant drugs such as cocaine and METH can directly activate σ1R in agonist-dependent manner (<xref ref-type="bibr" rid="B172">Sharkey et al., 1988</xref>; <xref ref-type="bibr" rid="B75">Kahoun and Ruoho, 1992</xref>; <xref ref-type="bibr" rid="B117">Nguyen et al., 2005</xref>; <xref ref-type="bibr" rid="B25">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="B61">Hayashi and Su, 2007</xref>; <xref ref-type="bibr" rid="B62">Hayashi et al., 2011</xref>).</p>
<sec id="S3.SS1.SSS1">
<title>DA- and Monoamine-Independent Mechanisms</title>
<p>Rising evidence suggests that cocaine addiction also involves regional-specific alterations in intrinsic excitability (<xref ref-type="bibr" rid="B115">Nasif et al., 2005</xref>; <xref ref-type="bibr" rid="B40">Dong et al., 2006</xref>; <xref ref-type="bibr" rid="B71">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="B87">Kourrich and Thomas, 2009</xref>; for a review, see <xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>). Specifically, it is well established that cocaine experience alters several VGICs, including Na<sup>+</sup>, Ca<sup>2+</sup>, and K<sup>+</sup> conductances in NAc neurons (<xref ref-type="bibr" rid="B220">Zhang et al., 1998</xref>, <xref ref-type="bibr" rid="B219">2002</xref>; <xref ref-type="bibr" rid="B69">Hu et al., 2004</xref>). Alterations of these channels are all consistent with decreased NAc MSNs intrinsic excitability (<xref ref-type="bibr" rid="B40">Dong et al., 2006</xref>; <xref ref-type="bibr" rid="B71">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="B87">Kourrich and Thomas, 2009</xref>; <xref ref-type="bibr" rid="B113">Mu et al., 2010</xref>). This adapatation is characterized by a decreased ability of neurons to trigger action potentials, and will be referred to as neuronal hypoactivity. However, evidence from both biophysical and pharmacological approaches found that the slowly inactivating A-type K<sup>+</sup> current (also called D-type, <italic>I</italic><sub><italic>D</italic></sub>) (<xref ref-type="bibr" rid="B87">Kourrich and Thomas, 2009</xref>; <xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>) and the small conductance Ca<sup>2+</sup>-activated K<sup>+</sup> current (SK type) (<xref ref-type="bibr" rid="B71">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="B113">Mu et al., 2010</xref>) play a significant role in the expression of cocaine-induced neuronal hypoactivity. Importantly, this neuroadaptation is observed after weeks of cocaine abstinence from both non-contingent intraperitoneal injection (<xref ref-type="bibr" rid="B71">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="B87">Kourrich and Thomas, 2009</xref>) and contingent intravenous cocaine self-administration (<xref ref-type="bibr" rid="B170">Segev et al., 2018</xref>; <xref ref-type="bibr" rid="B202">Wang et al., 2018</xref>).</p>
<p>Whereas enhanced DA signaling is accepted as the canonical mechanism initiating addictive processes, evidence indicates that cocaine also triggers non-canonical, DA-independent mechanism(s) that contribute to addiction (<xref ref-type="bibr" rid="B176">Sora et al., 1998</xref>), some of which involve σ1R (<xref ref-type="bibr" rid="B47">Garces-Ramirez et al., 2011</xref>; <xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>; <xref ref-type="bibr" rid="B67">Hiranita et al., 2013</xref>; reviewed in <xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>, <xref ref-type="bibr" rid="B78">2016</xref>). These mechanisms are not excluding the critical role of DA in the development of stimulant addiction; however, unconventional DA-independent (or monoamine-independent) are still underestimated by the scientific community. Recent studies demonstrate that cocaine-induced neuronal hypoactivity in NAc shell MSNs is independent of DA, and potentially other monoamine signaling (<xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). In particular, upon both <italic>in vivo</italic> and <italic>in vitro</italic> cocaine exposure, σ1R associates with Kv1.2 channels, a channel that drives <italic>I</italic><sub><italic>D</italic></sub> in striatal MSNs (<xref ref-type="bibr" rid="B173">Shen et al., 2004</xref>). This mechanism promotes Kv1.2 trafficking from the ER to the plasma membrane, which enhances <italic>I</italic><sub><italic>D</italic></sub>, decreases neuronal firing, and thereby enhances behavioral response to cocaine (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Consistent with a DA-independent mechanism, cocaine-induced σ1R-Kv1.2 protein-protein associations and enhanced membrane Kv1.2 also occurs in HEK293T cells that are devoid of DARs. Although other voltage- and Ca2<sup>+</sup>-gated ion channels are thought to contribute to cocaine-induced neuronal hypoactivity (<xref ref-type="bibr" rid="B220">Zhang et al., 1998</xref>, <xref ref-type="bibr" rid="B219">2002</xref>; <xref ref-type="bibr" rid="B69">Hu et al., 2004</xref>; <xref ref-type="bibr" rid="B71">Ishikawa et al., 2009</xref>) and that σ1R can modulate all classes of VGICs (<xref ref-type="fig" rid="F1">Figure 1A</xref>), it is still unknown whether changes in these channels after exposure to cocaine implicate σ1R-dependent trafficking mechanisms.</p>
<p>While conventional mechanisms of actions for abused substances involve extracellular targets, DA transporters (DAT) (and other monoamine transporters) in the case of psychostimulant drugs, work form Henry Lester’s group provide an alternative hypothesis. Here, drugs of abuse or psychiatric drugs in physiological milieu coexist with their deprotonoted form (membrane permeant). These neutral forms can freely diffuse through the plasma membrane and act directly on intracellular targets. σ1R is enriched in intracellular organelles, especially at the ER level. Binding assays carried out on cell homogenates — a preparation that nevertheless does not preserve plasma membrane integrity — showed that cocaine, at doses found to be rewarding in rodents, binds to σ1R (<xref ref-type="bibr" rid="B75">Kahoun and Ruoho, 1992</xref>; <xref ref-type="bibr" rid="B25">Chen et al., 2007</xref>). Using a combination of <italic>in vitro</italic> molecular and electrophysiological approaches in HEK293T cells and NAc shell brain slices, respectively, <xref ref-type="bibr" rid="B35">Delint-Ramirez et al. (2018)</xref> demonstrated that cocaine binding to intracellular σ1R initiates the mechanism responsible for MSNs hypoactivity. Together, this suggests that beyond canonical DA-driven mechanisms initiated by extracellular actions of cocaine, cocaine also exerts its addictive properties <italic>via</italic> intracellular actions triggered by direct binding to σ1R (<xref ref-type="bibr" rid="B47">Garces-Ramirez et al., 2011</xref>; <xref ref-type="bibr" rid="B67">Hiranita et al., 2013</xref>; reviewed in <xref ref-type="bibr" rid="B78">Katz et al., 2016</xref>). This is consistent with the work form Dr. Katz group demonstrating that animals with cocaine experience self-administer σ1R agonists (e.g., PRE-084 and (+)-Pentazocine) (<xref ref-type="bibr" rid="B67">Hiranita et al., 2013</xref>) at doses that do not induce DA release in the NAc shell (<xref ref-type="bibr" rid="B47">Garces-Ramirez et al., 2011</xref>; reviewed in <xref ref-type="bibr" rid="B78">Katz et al., 2016</xref>). This switch in reinforcement does not occur after experience with food reinforcement (reviewed in <xref ref-type="bibr" rid="B78">Katz et al., 2016</xref>).</p>
<p>Importantly, METH, a psychostimulant drug that is structurally distinct from cocaine and that exhibits high addiction liability, also depresses NAc shell neuronal excitability (<xref ref-type="bibr" rid="B50">Graves et al., 2015</xref>), an effect that may be triggered by METH binding to σ1R (<xref ref-type="bibr" rid="B117">Nguyen et al., 2005</xref>). Indeed, structural and crystallography studies found that σ1R ligand-binding cavity is capable of binding structurally different compounds (<xref ref-type="bibr" rid="B184">Su et al., 2010</xref>; <xref ref-type="bibr" rid="B167">Schmidt et al., 2016</xref>).</p>
</sec>
<sec id="S3.SS1.SSS2">
<title>Putative DA-Dependent Synergistic Mechanisms</title>
<p>In regards to the implication of σ1R in the development of addictive processes, σ1R and DA 1 receptors (D1Rs) can form heteromers. Cocaine binding to this complex amplifies D1R-mediated increases in cyclic AMP (cAMP), a mechanism that appears to occur in mouse striatum (<xref ref-type="bibr" rid="B116">Navarro et al., 2010</xref>). Although the complex formed by the D1R and σ1R appears to amplify PKA signaling, the mechanisms by which this adaptation contributes to cocaine addiction has not been identified yet. A putative mechanism may be the activation of PKA and thereby the inhibition of striatal <italic>I</italic><sub><italic>D</italic></sub> current, which is expected to enhance neuronal firing. Indeed, previous studies indicate that inhibiting PKA pathways decreases neuronal firing (<xref ref-type="bibr" rid="B68">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="B134">Perez et al., 2006</xref>), therefore excluding this scenario as a putative mechanism for cocaine-induced neuronal hypoactivity in NAc shell MSNs, a mechanism that occurs in D1R- but not in DA 2 receptors (D2R)-containing MSNs (<xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). An important consideration to take account is that although the complex formed by the D1R and the σ1R occurs, the ability for cocaine to activate this protein complex <italic>in vivo</italic> is yet to be demonstrated. Indeed, authors applied cocaine <italic>in vitro</italic> at 30–300 μM (<xref ref-type="bibr" rid="B116">Navarro et al., 2010</xref>), a concentration that exhibits off-target effects, especially on VGICs (<xref ref-type="bibr" rid="B146">Reith et al., 1986</xref>; <xref ref-type="bibr" rid="B221">Zimanyi et al., 1989</xref>; <xref ref-type="bibr" rid="B205">Wheeler et al., 1993</xref>; <xref ref-type="bibr" rid="B121">O’Leary and Chahine, 2002</xref>; <xref ref-type="bibr" rid="B213">Xiao et al., 2004</xref>; <xref ref-type="bibr" rid="B26">Chen et al., 2006</xref>). Furthermore, this concentration range is significantly beyond cocaine concentration found in the brain upon exposure to standard non-toxic rewarding dose (l–3 μM) (<xref ref-type="bibr" rid="B136">Pettit et al., 1990</xref>), and even higher than the total serum concentrations of cocaine (&gt;10 μM) that produce toxicity in humans (<xref ref-type="bibr" rid="B195">Van Dyke et al., 1976</xref>; <xref ref-type="bibr" rid="B123">Paly et al., 1982</xref>; <xref ref-type="bibr" rid="B43">Escobedo et al., 1991</xref>). Nonetheless, assuming that σ1R-D1R complex plays a role in the behavioral effects of cocaine, the signaling pathway that is initiated does not seem to result in changes in intrinsic postsynaptic neuronal excitability. One possible mechanism by which this heteromeric complex may contribute to addictive processes may be by enhancing presynaptic glutamate release in prelimbic cortex (<xref ref-type="bibr" rid="B39">Dong et al., 2007</xref>), a region in brain reward circuits that is critical for initiating cocaine seeking and relapse to drug seeking behaviors (<xref ref-type="bibr" rid="B104">McFarland and Kalivas, 2001</xref>; <xref ref-type="bibr" rid="B21">Capriles et al., 2003</xref>; <xref ref-type="bibr" rid="B105">McFarland et al., 2003</xref>, <xref ref-type="bibr" rid="B103">2004</xref>; <xref ref-type="bibr" rid="B106">McLaughlin and See, 2003</xref>; for reviews, see <xref ref-type="bibr" rid="B76">Kalivas and O’Brien, 2008</xref>; <xref ref-type="bibr" rid="B135">Peters et al., 2009</xref>).</p>
<p>An intriguing candidate mechanism that may also implicate DAR-activated kinases in the regulation of neuronal intrinsic excitability is the activation of the α-isoform of calcium/calmodulin-dependent protein kinase II (αCaMKII). Indeed, D1R activation enhances αCaMKII (CaMKII-pThr286) (<xref ref-type="bibr" rid="B3">Anderson et al., 2008</xref>), and besides its established role in glutamate AMPAR trafficking to the surface, αCaMKII regulates surface K<sup>+</sup> channel density and currents directly, especially A-type K<sup>+</sup> currents (<xref ref-type="bibr" rid="B214">Yao and Wu, 2001</xref>; <xref ref-type="bibr" rid="B197">Varga et al., 2004</xref>; <xref ref-type="bibr" rid="B171">Sergeant et al., 2005</xref>). A previous study found that mice that overexpress a constitutively active form of striatal neuron-specific αCaMKII (in which Thr286 is mutated to Asp) exhibit a decreased MSN firing capacity in the NAc shell in the absence of any detectable changes in glutamate transmission (<xref ref-type="bibr" rid="B85">Kourrich et al., 2012a</xref>). Interestingly, while σ1R also has the capability to increase αCaMKII-pThr286 (<xref ref-type="bibr" rid="B111">Moriguchi et al., 2011</xref>), whether this mechanism is downstream of D1R activation and results in modulation of neuronal firing is yet to be investigated.</p>
</sec>
<sec id="S3.SS1.SSS3">
<title>Behavioral Relevance</title>
<p>From a behavioral viewpoint, neurobiological manipulations that promotes NAc neuronal hypoactivity (e.g., viral enhancement of K<sup>+</sup> currents or via overexpression of αCaMKII-pThr286) enhances rewarding properties of cocaine (<xref ref-type="bibr" rid="B85">Kourrich et al., 2012a</xref>) and produce a hypersensitivity to cocaine’s psychomotor effects (<xref ref-type="bibr" rid="B40">Dong et al., 2006</xref>; <xref ref-type="bibr" rid="B85">Kourrich et al., 2012a</xref>)—a mechanism that is thought to contribute to the transition from recreational to compulsive drug use (<xref ref-type="bibr" rid="B44">Ferrario et al., 2005</xref>; <xref ref-type="bibr" rid="B150">Robinson and Berridge, 2008</xref>). At the circuit level, enhanced behavioral response to cocaine following inhibition of NAc shell neurons is thought to be driven by the disinhibition of downstream reward-related brain regions. In sum, the decreased neuronal intrinsic excitability in the NAc shell is an adaptation sufficient to promote addiction phenotype and is now considered as one of the hallmarks for cocaine addiction (reviewed in <xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>). This adaptation is also consistent with the predominant tonic inhibition in NAc shell during short-access cocaine self-administration sessions (<xref ref-type="bibr" rid="B132">Peoples et al., 1998</xref>, <xref ref-type="bibr" rid="B131">1999</xref>; <xref ref-type="bibr" rid="B129">Peoples and Cavanaugh, 2003</xref>) and the role of the NAc hypoactivity in cocaine behavioral effects (<xref ref-type="bibr" rid="B130">Peoples et al., 2007</xref>).</p>
<p>Together, accumulating evidence demonstrate that in addition to the established role of DA in initiating and shaping addiction-relevant behaviors, cocaine (and potentially other psychostimulant drugs) engages unidentified mechanisms that also contribute to shaping the addiction phenotype (<xref ref-type="bibr" rid="B88">Kuribara and Uchihashi, 1993</xref>; <xref ref-type="bibr" rid="B100">Mattingly et al., 1994</xref>; <xref ref-type="bibr" rid="B206">White et al., 1998</xref>; <xref ref-type="bibr" rid="B142">Prinssen et al., 2004</xref>). Accordingly, a recent review from David J. Nutt and colleagues discusses evidence that enhanced DA release in the brain may not be the sole mediator or initiator for addictive processes (<xref ref-type="bibr" rid="B119">Nutt et al., 2015</xref>). This underscores the high clinical significance for identifying novel mechanisms of actions for drugs of abuse, e.g., DA-independent, which would stimulate the development of novel and combinatorial pharmacotherapies to treat stimulant abuse or to provide alternatives for individuals resistant to conventional treatments.</p>
<p>In a larger extent, the discovery that σ1R can form complexes with specific VGICs and that these protein complexes can undergo enduring experience-dependent maladaptive plasticity suggests new mechanistic hypotheses for other neuropsychiatric disorders that are associated with alterations in σ1R and VGICs functions (e.g., Alzheimer’s’ disease and multiple sclerosis).</p>
</sec>
</sec>
<sec id="S3.SS2">
<title>Cancer</title>
<sec id="S3.SS2.SSS1">
<title>Ion Channels in Cancers</title>
<p>While the presence of ion channels has been observed for decades in cancer cell lines (<xref ref-type="bibr" rid="B183">Strobl et al., 1995</xref>), the understanding of their influence on cancer biology has only emerged recently. Instability in cancer cell genotypes induce several pathological features (hallmarks) including proliferation, resistance to apoptosis, epithelial to mesenchymal transition, tissue invasion and angiogenesis (<xref ref-type="bibr" rid="B56">Hanahan and Weinberg, 2011</xref>). Moreover, cancer cells entertain a dynamic bi-directional dialog with their local microenvironment, formed by cancer-activated fibroblasts, immune cell, blood vessels and proteins of the extra-cellular matrix, triggering signaling pathways shaping the development of the disease (<xref ref-type="bibr" rid="B143">Quail and Joyce, 2013</xref>). A general scheme has emerged in which ion channels shape an electrical signature that accompanies all steps of disease development, relapse and finally patient survival (<xref ref-type="bibr" rid="B212">Wulff et al., 2009</xref>; <xref ref-type="bibr" rid="B126">Pardo and Stuhmer, 2014</xref>; <xref ref-type="bibr" rid="B5">Arcangeli and Becchetti, 2017</xref>; <xref ref-type="bibr" rid="B145">Rapetti-Mauss et al., 2017</xref>; <xref ref-type="bibr" rid="B141">Prevarskaya et al., 2018</xref>; <xref ref-type="bibr" rid="B13">Becchetti et al., 2019</xref>).</p>
</sec>
<sec id="S3.SS2.SSS2">
<title>σ1R in Cancers</title>
<p>The functional relationships between σ1R and ion channels in the central nervous system (CNS) raises the question of the function of the chaperone in cancers. In the 1990’s, several teams pointed out the presence of high densities of σ1R in cancer cell lines (i.e., glioblastoma, neuroblastoma, leukemia, breast cancer, melanoma, prostate or lung cancer cell lines) and suggested that it could be involved in cancer cell biology since sigma ligands (e.g., BD737) decreased cell proliferation or induced cell death <italic>in vitro</italic> (<xref ref-type="bibr" rid="B199">Vilner et al., 1995a</xref>, <xref ref-type="bibr" rid="B200">b</xref>). Despite the large number of publications dealing with σ1R and cancer, most of the knowledge until recently came from descriptive pharmacological studies with few answers regarding the innate function of the protein in disease progression as well as the molecular mechanisms involved. However, the evolution of the concept of σ1R from a classical receptor to a ligand-regulated chaperone protein has been accompanied by new information on its functions in cancer cell biology.</p>
<p>Spruce and collaborators showed that σ1R expression in breast and prostate cancer cells induced a break on Caspase-3-dependent apoptosis that could be attenuated by the σ1R antagonist rimcazole, in turn reducing tumor growth and metastatic proliferation in mice xenograft models. Accordingly, the effects of rimcazole could be attenuated by the σ1R agonists SKF10.047 and (+)-pentazocine (<xref ref-type="bibr" rid="B182">Spruce et al., 2004</xref>). In Jurkat T cell lines, it was observed that σ1R expression increased cell resistance to thapsigargin-induce apoptotic volume decrease (AVD), an early step in cell death process (<xref ref-type="bibr" rid="B147">Renaudo et al., 2007</xref>). In Jurkat and small cell lung cancer cells (NCI-H209), sigma ligands [igmesine and (+)-pentazocine] blocked cell cycle by inhibiting regulatory volume decrease (RVD), a mechanism related to AVD and that is required for G1/S transition (<xref ref-type="bibr" rid="B148">Renaudo et al., 2004</xref>). Overexpression of σ1R when compared to healthy tissues is also observed in colorectal (CRC) and myeloid leukemia (ML). In these cancers, σ1R promotes integrin-dependent invasive process <italic>in vitro</italic> and <italic>in vivo</italic>. In breast cancer patients, σ1R expression correlates with reduced overall survival; and at the cellular level, σ1R potentiates Ca<sup>2+</sup>-dependent migration, a mechanism also found in CRC cells (<xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>; <xref ref-type="bibr" rid="B54">Gueguinou et al., 2017</xref>). In prostate cancer, a recent study revealed that σ1R expression contributes to cell resistance to ER stress, and to the development of treatment-induced castration-resistant prostate cancer by promoting androgen receptor resurgence (<xref ref-type="bibr" rid="B189">Thomas et al., 2017</xref>).</p>
<p>Altogether, these results suggest that σ1R plays a significant role in cancer cell by regulating ion channel-related mechanisms (e.g., AVD, RVD, integrin signaling, Ca<sup>2+</sup> homeostasis) (<xref ref-type="bibr" rid="B8">Aydar et al., 2016</xref>; <xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>; <xref ref-type="bibr" rid="B55">Guéguinou et al., 2016</xref>; <xref ref-type="bibr" rid="B179">Soriani and Rapetti-Mauss, 2017</xref>; <xref ref-type="bibr" rid="B144">Rapetti-Mauss et al., 2018</xref>).</p>
<sec id="S3.SS2.SSS2.Px1">
<title>Cancer cell growth and volume regulation</title>
<p>Cancer cell growth is the result of a balance between cell division and cell apoptosis. Early works by Bowen and coworkers back in the 1990s revealed that incubation of cancer cell lines with sigma ligands such as haloperidol and BD737 impaired cell growth <italic>in vitro</italic>. Interestingly, cell growth arrest was accompanied by a cellular swelling (<xref ref-type="bibr" rid="B199">Vilner et al., 1995a</xref>). Further works revealed that sigma ligands such as (+)-pentazocine or igmesine induced a cell swelling <italic>in vitro</italic> by inhibiting Kv and volume regulated chloride channels (VRAC). In fact, these two channels are the main effectors of the RVD process, allowing, in response to hypo-osmotic challenge, cell volume recovery by allowing potassium chloride (KCl) and osmotic water efflux (through activation of K<sup>+</sup> and chloride channels). RVD is required for cells to pursue their cell cycle through the G1/S phase transition (<xref ref-type="bibr" rid="B157">Rouzaire-Dubois and Dubois, 1998</xref>; <xref ref-type="bibr" rid="B158">Rouzaire-Dubois et al., 2000</xref>). Accordingly, in SCLC and leukemia cell lines, inhibition of Kv and VRAC channels by σ1R ligands provoked accumulation of the p27kip1, and a decrease in cyclin A contents, reflecting an arrest of cell cycle at the end of the G1 phase (<xref ref-type="bibr" rid="B148">Renaudo et al., 2004</xref>, <xref ref-type="bibr" rid="B147">2007</xref>). Cell volume regulation is also an important feature in the context of cell death. Indeed, cell shrinking by water efflux following activation of VRAC and K<sup>+</sup> channels, is an early event of apoptosis signaling (<xref ref-type="bibr" rid="B95">Maeno et al., 2000</xref>; <xref ref-type="bibr" rid="B89">Lambert et al., 2008</xref>). In the studies performed by Renaudo and colleagues (2004, 2007), several clues indicated that σ1R was also involved in cell response to apoptosis. In leukemia T cells, the sigma ligand igmesine reduced VRAC current density and delayed staurosporine-induced AVD. Experiments in HEK293 cells showed that σ1R overexpression decreased volume-regulated chloride channels (VRCC) activation rate and delayed stausporine-induced AVD.</p>
<p>Taken together, these data suggest that σ1R expression in cancer provides cells better resistance capacity to apoptotic signals. Indeed, the tonic brake exerted by σ1R on VRAC channel activation rate restricts AVD without impeding RVD, the latter being necessary for cell cycle progression (<xref ref-type="bibr" rid="B147">Renaudo et al., 2007</xref>). This idea, in which σ1R exerts membrane-channel dependent pro-survival function seems to mirror the model proposed by Hayashi and Su in which σ1R, by chaperoning IP3R at the mitochondrion-associated ER membrane (MAM), stimulates CHO cell resistance to ER stress-induced apoptosis (<xref ref-type="bibr" rid="B61">Hayashi and Su, 2007</xref>).</p>
</sec>
<sec id="S3.SS2.SSS2.Px2">
<title>Calcium influx and cell migration</title>
<p>In cancer, mortality is mainly the consequence of metastasis spreading, a complex process requiring the capacity of cells to migrate from the primary site and disseminate. Among the cellular processes involved in cell migration, Ca<sup>2+</sup> homeostasis is crucial. Indeed, a deep Ca<sup>2+</sup> influx remodeling occurs during the development of the disease and recent findings have revealed the formation of gain-of-function ion channel platforms at the plasma membrane as key events for metastasis progression (<xref ref-type="bibr" rid="B53">Guéguinou et al., 2014</xref>; <xref ref-type="bibr" rid="B108">Monteith et al., 2017</xref>). In breast and colorectal cancers (BC and CRC), σ1R is required to trigger the physical and functional coupling between the Ca<sup>2+</sup> channel Orai1 and the Ca<sup>2+</sup>-dependent K<sup>+</sup> channel SK3 (<italic>KCNN3</italic>). The group of Vandier has shown that the coupling of these two channels within cholesterol-rich membrane nanodomains (labeled by the presence of Caveolin1) potentiated constitutive (in BC) or capacitive (in CRC) Ca<sup>2+</sup> influx, which in turn stimulated cell migration and bone metastasis formation in BC (<xref ref-type="bibr" rid="B24">Chantôme et al., 2013</xref>; <xref ref-type="bibr" rid="B55">Guéguinou et al., 2016</xref>). Co-immunoprecipitation and FRET assays demonstrated that σ1R binds SK3. Furthermore, σ1R silencing abrogated SK3-dependent Ca<sup>2+</sup> influx and migration by chasing both SK3 and Orai1 out of caveolae lipid nanodomains. Interestingly, the sigma ligand igmesine mimicked these effects on Ca<sup>2+</sup> influx and migration by dissociating Orai1 from SK3, the former being excluded from lipid caveolae nanodomains in MDA MB 435s BC cells. Noteworthy, σ1R is overexpressed in CRC and BC human samples and is associated with higher-grade tumors in CRC and reduced overall survival in BC patients (<xref ref-type="bibr" rid="B54">Gueguinou et al., 2017</xref>).</p>
</sec>
<sec id="S3.SS2.SSS2.Px3">
<title>Na<sub><italic>v</italic></sub>1.5 channels and invasiveness</title>
<p>Voltage-gated sodium channels (VGSC) have been extensively characterized for their electrogenic functions in cell excitability (action potential firing). During the last decade, an increasing number of studies have described the anomalous expression of VGSC in epithelial cancers where they are associated to motility or invasiveness, therefore increasing the risk of metastasis development. In particular, the neonatal form of Na<sub><italic>v</italic></sub>1.5 α-subunit (SCN5A) has been observed in breast cancers where it generates a tonic inward Na<sup>+</sup> current (in other words a window current) (<xref ref-type="bibr" rid="B154">Roger et al., 2006</xref>). It was shown that Na<sup>+</sup> entry through VGSC leads to the formation and activity of invadopodia with the polymerization of actin and increase in Na<sup>+</sup>-H<sup>+</sup> exchanger type 1 (NHE1) activity. This mechanism contributes to the acidification of the extracellular surface of the plasma membrane, making a favorable milieu for the activity of acidic cysteine cathepsins (reviewed in <xref ref-type="bibr" rid="B17">Brisson et al., 2013</xref>). As previously mentioned, σ1R binds Na<sub><italic>v</italic></sub>1.5 with a fourfold symmetry (one σ1R per set of six transmembrane domains). At a more functional level, σ1R silencing in the metastatic breast cancer cell line MDA-MD-231 led to a significant decrease in Na<sub><italic>v</italic></sub>1.5 current density, suggesting that the presence of the chaperone in BC cells potentiates their invasive potency (<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>). Interestingly, further studies showed in the same cell line that the functional coupling between σ1R and Na<sub><italic>v</italic></sub>1.5 was also involved in cell adhesion properties, but not in cell proliferation or migration (<xref ref-type="bibr" rid="B8">Aydar et al., 2016</xref>).</p>
</sec>
<sec id="S3.SS2.SSS2.Px4">
<title>hERG and ECM-induced invasive phenotype</title>
<p>Integrin-mediated cell adhesion has a pivotal role on cell fate determination and is intimately associated with ion transport. Ion channels and integrins form signaling hubs that recruits membrane receptors involved in proliferation, migration, differentiation, invasion or angiogenesis. A growing number of studies indicates that ion channels regulate signaling pathways downstream integrin activation by the ECM. Remarkably, their association with integrins determines their open probability, which in turn influences downstream pathways (reviewed in <xref ref-type="bibr" rid="B13">Becchetti et al., 2019</xref>). hERG K<sup>+</sup> channel has been pointed out as a partner of several integrins and is prognostic a marker in several solid tumors and leukemias. As stated above, σ1R binds hERG α-subunits and enhances hERG trafficking to the plasma membrane in K562 leukemia cells or transfected HEK293 cells, leading to increased current density (<xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>; <xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>). In myeloid leukemia and CRC, the rapid association of hERG with the β1 subunit of integrin upon ECM stimulation requires σ1R. The silencing of the chaperone abolishes both ECM-induced stimulation of hERG and PI3/AKT pathway downstream of integrin stimulation. Consequently, σ1R inhibition reduces migration, angiogenesis and metastasis spreading <italic>in vitro</italic> and <italic>in vivo</italic> using zebra fish and mice models (<xref ref-type="bibr" rid="B9">Balasuriya et al., 2014</xref>; <xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>). These data demonstrate that σ1R dynamically shapes cancer cell electrical signature in response to the tumor microenvironment. The role of σ1R in electrical plasticity within the cancer tissue obviously contributes to the signaling underlying the phenotypic adaptation of cancer cells to a highly stringent environment.</p>
<p>Altogether, these results suggest that the innate pro-adaptive function of σ1R is hijacked to the benefit of tumor development.</p>
</sec>
</sec>
</sec>
</sec>
<sec id="S4">
<title>A Unifying Theory</title>
<p>Due to their critical role in regulating trafficking and functions of VGICs, knocking-out classical ion channels’ auxiliary subunits alters a variety of cellular functions (<xref ref-type="bibr" rid="B49">Giese et al., 1998</xref>; <xref ref-type="bibr" rid="B139">Pongs et al., 1999</xref>; <xref ref-type="bibr" rid="B194">Vacher et al., 2008</xref>; <xref ref-type="bibr" rid="B186">Sun et al., 2011</xref>; <xref ref-type="bibr" rid="B99">Martinez-Espinosa et al., 2014</xref>), which can lead to various chronic diseases such as long QT syndrome (<xref ref-type="bibr" rid="B168">Schulze-Bahr et al., 1997</xref>; <xref ref-type="bibr" rid="B181">Splawski et al., 1997</xref>), epilepsy (<xref ref-type="bibr" rid="B64">Heilstedt et al., 2001</xref>) and even premature death (<xref ref-type="bibr" rid="B6">Arikkath and Campbell, 2003</xref>). In contrast, σ1R KO mice are viable and do not exhibit clear behavioral and physiological phenotypes (<xref ref-type="bibr" rid="B90">Langa et al., 2003</xref>), raising the hypothesis that σ1R becomes critical only when the system is challenged.</p>
<p>Indeed, σ1R KO mice exhibit behavioral deficits when confronted to novel situations that require behavioral adaptations, such as during learning and memory tasks (<xref ref-type="bibr" rid="B42">Entrena et al., 2009</xref>; <xref ref-type="bibr" rid="B27">Chevallier et al., 2011</xref>) and during stressful and anxiogenic situations that require coping mechanisms (<xref ref-type="bibr" rid="B163">Sabino et al., 2009</xref>; <xref ref-type="bibr" rid="B27">Chevallier et al., 2011</xref>). Similarly, in the context of neuronal electrical activity, preventing σ1R activation with various antagonists both in freely moving animals or <italic>in vitro</italic> does not alter Na<sup>+</sup> currents (<xref ref-type="bibr" rid="B218">Zhang et al., 2009</xref>), Ca<sup>2+</sup> dynamics (<xref ref-type="bibr" rid="B188">Tchedre et al., 2008</xref>; <xref ref-type="bibr" rid="B34">Cuevas et al., 2011</xref>; <xref ref-type="bibr" rid="B124">Pan et al., 2014</xref>) and K<sup>+</sup> currents (<xref ref-type="bibr" rid="B84">Kourrich et al., 2013</xref>). In fact, these findings suggest that σ1R’s functions are not necessary in situations that are not threatening the biological integrity of the individual. This idea is further supported by studies demonstrating that σ1R ligands activation exhibit robust neuroprotective properties, such as reducing infarct volume after embolic stroke (<xref ref-type="bibr" rid="B2">Allahtavakoli and Jarrott, 2011</xref>), preventing apoptotic retinal ganglion cell death induced by glutamate and excitotoxic perinatal brain injury (<xref ref-type="bibr" rid="B51">Griesmaier et al., 2012</xref>). σ1R ligands also rescue various behavioral and biological deficits associated with amnesia, depression, neuropathic pain, cocaine-induced immune alteration and HIV expression, and Alzheimer’s disease (<xref ref-type="bibr" rid="B101">Maurice and Su, 2009</xref>). In stark contrast with these protective properties of σ1R activation, ligand activation of σ1R contributes to tumor growth (<xref ref-type="bibr" rid="B31">Crottès et al., 2013</xref>) and the development of psychostimulant addiction (<xref ref-type="bibr" rid="B79">Katz et al., 2011</xref>, <xref ref-type="bibr" rid="B78">2016</xref>). Based on these findings, we speculate that primary σ1R’s functions, which are to preserve cellular health and survival, are hijacked to contribute to maladaptive cellular functions, thereby leading to chronic diseases such as cancer and stimulant addiction.</p>
<sec id="S4.SS1">
<title>Stimulant Addiction</title>
<p>Besides their rewarding properties, cocaine and other psychostimulants drugs trigger neurotoxic mechanisms (<xref ref-type="bibr" rid="B133">Pereira et al., 2015</xref>). This toxicity originates from various drugs’ mechanisms of actions, such as supraphysiological elevation of extracellular DA. While enhanced DA signaling contributes to the rewarding properties of psychostimulant drugs, it also induces oxidative stress and associated neuronal apoptosis (<xref ref-type="bibr" rid="B133">Pereira et al., 2015</xref>). Indeed, increase of oxidative stress in brain regions associated with the brain reward circuits (NAc, frontal cortex, and hippocampus) (<xref ref-type="bibr" rid="B37">Dietrich et al., 2005</xref>; <xref ref-type="bibr" rid="B114">Muriach et al., 2010</xref>; <xref ref-type="bibr" rid="B72">Jang et al., 2015</xref>) upregulates pro-inflammatory mediators (e.g., cytokines and chemokines) or astroglia/microglia activation (<xref ref-type="bibr" rid="B149">Renthal et al., 2009</xref>; <xref ref-type="bibr" rid="B138">Piechota et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Blanco-Calvo et al., 2014</xref>; <xref ref-type="bibr" rid="B91">Lopez-Pedrajas et al., 2015</xref>; see review <xref ref-type="bibr" rid="B133">Pereira et al., 2015</xref>). Interestingly, a physiologically relevant concentration of DA that does not cause apoptosis becomes toxic in σ1R knockdown cells (<xref ref-type="bibr" rid="B110">Mori et al., 2012</xref>), consistent with neuroprotective and other associated positive effects of σ1R ligands activation on various chronic neurodegenerative diseases such as Alzheimer’s (<xref ref-type="bibr" rid="B161">Ryskamp et al., 2019</xref>) and Huntington’s diseases (<xref ref-type="bibr" rid="B15">Bol’shakova et al., 2017</xref>; <xref ref-type="bibr" rid="B160">Ryskamp et al., 2017</xref>; see review <xref ref-type="bibr" rid="B19">Cai et al., 2017</xref>). Indeed, σ1R agonist PRE-084 reduces oxidative species, calcium flux and other inflammatory molecules [including interleukin (IL) IL-1β, IL-6, IL-8 and tumor necrosis factor alpha (TNFα)] in various cell types (<xref ref-type="bibr" rid="B77">Katnik et al., 2006</xref>; <xref ref-type="bibr" rid="B187">Szabo et al., 2014</xref>). As such, we speculate that identified cocaine-driven σ1R mechanism associated with the development of cocaine addiction may be initially a neuroprotective mechanism aimed to counteract deleterious effect of psychostimulant drugs of abuse on neuronal health. Here, we present a hypothesis that may provide clues onto the dual effect of σ1R activation, aimed primarily to be pro-survival but could be hijacked to promote the development of addiction to psychostimulant drugs.</p>
<p>Today, we know that repeated cocaine exposure leads to several long-lasting neuroadaptations in the brain reward circuits (<xref ref-type="bibr" rid="B93">Luscher and Malenka, 2011</xref>; <xref ref-type="bibr" rid="B209">Wolf and Tseng, 2012</xref>; <xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>; <xref ref-type="bibr" rid="B208">Wolf, 2016</xref>). The mechanisms through which these neuroadaptations are initiated and their contributions to shaping lasting changes in behavior are active fields of research. A recent study provided direct evidence that persistent cocaine-induced neuronal hypoactivity in the NAc shell, now considered as one of the hallmarks for cocaine addiction, is initiated by σ1R activation (<xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>). This adapatation of the NAc shell neurons is characterized by a decreased ability for neurons to trigger action potentials and is associated with enhanced hyperpolarizing and decreased depolarizing membrane ion channels. It is tempting to speculate that the primary function of this early σ1R-driven mechanism is to protect the neuron from cocaine-induced cytotoxic mechanisms, a scenario supported by indirect evidence from two lines of studies. Specifically, cocaine administration induces an early increase of membrane NMDA glutamate receptors (NMDARs) in the NAc shell, especially receptors that contain the GluN2B subunit. These GluN2B-containing NMDARs appear to contribute to the development of further lasting changes in glutamate neurotransmission in the reward circuits and thereby may participate to the development of cocaine addiction (<xref ref-type="bibr" rid="B41">Dong and Nestler, 2014</xref>). NMDARs are highly permeable to Ca<sup>2+</sup> and inclusion of GluN2B subunits further prolongs Ca<sup>2+</sup> entry (<xref ref-type="bibr" rid="B109">Monyer et al., 1994</xref>; <xref ref-type="bibr" rid="B198">Vicini et al., 1998</xref>; <xref ref-type="bibr" rid="B159">Rumbaugh and Vicini, 1999</xref>; <xref ref-type="bibr" rid="B165">Schilstrom et al., 2006</xref>). NMDAR-induced Ca<sup>2+</sup> neurotoxicity is one of the primary factor that leads to cell damage (see review <xref ref-type="bibr" rid="B127">Pchitskaya et al., 2018</xref>). A recent study showed that <sc>D</sc>-cycloserine (DCS), an agonist of NMDARs, leads to decreased neuronal excitability, and disrupting GluN2B prevents both this mechanism and cocaine-induced neuronal hypoactivity in the NAc shell (<xref ref-type="bibr" rid="B202">Wang et al., 2018</xref>). Another study found that this same adaptation, i.e., cocaine-induced neuronal hypoactivity, is initiated by direct cocaine binding to σ1R (<xref ref-type="bibr" rid="B35">Delint-Ramirez et al., 2018</xref>).</p>
<p>Altogether, cocaine-induced neuronal hypoactivity in the NAc shell may originally be an adaptive mechanism aimed to counteract Ca<sup>2+</sup>-induced neurotoxicity. However, at the circuit level, decreased intrinsic excitability of MSNs, which are inhibitory projection neurons, is expected to disinhibit downstream reward-related brain regions and thereby promote addiction-relevant behaviors (reviewed in <xref ref-type="bibr" rid="B83">Kourrich et al., 2015</xref>). Consistent with this framework, Khoshbouei and colleagues found that σ1R activation decreases METH-stimulated DA efflux and prevents METH-induced, DAT-mediated increases in firing activity of DA neurons, which together may also play a role in limiting DA-induced neurotoxicity (<xref ref-type="bibr" rid="B164">Sambo et al., 2017</xref>). It is noteworthy to mention that METH is a psychostimulant drug that exhibits strong neurotoxic effects. Importantly, in both cocaine and METH studies, σ1R activation dampens neuronal firing. However, at the behavioral level, resulting effects of σ1R-driven inhibition of neuronal firing in the NAc shell MSNs or ventral tegmental area (VTA) DA neurons, which may be a mechanism limiting activity-dependent neurotoxicity, differentially affect rewarding properties of the drug. While this mechanism supports the role of σ1R in neuroprotection, its effects on the development or maintenance of stimulant abuse likely depends on its brain site of action. Taken together, this theory warrants further studies to elucidate brain region-specific mechanisms by which σ1R, likely depending on client proteins available, contributes to the development of stimulant abuse. This idea is further supported by a recent study demonstrating that cocaine administration induces a cascade of cellular mechanisms in the NAc that aim to counteract each other in homeostatic fashion (<xref ref-type="bibr" rid="B202">Wang et al., 2018</xref>), which ultimately heightens cocaine seeking after drug abstinence.</p>
</sec>
<sec id="S4.SS2">
<title>Cancer</title>
<p>During tumor development, cancer cells are facing intrinsic (oncogene activation) and extrinsic (limiting nutrient or oxygen supply, inflammation) challenges, with which they must cope to survive. Moreover, imbalance between protein folding demand and capacity in the ER leads to a situation of ER stress that is often observed in highly proliferative tumor cells (reviewed in <xref ref-type="bibr" rid="B125">Papaioannou et al., 2018</xref>; <xref ref-type="bibr" rid="B120">Obacz et al., 2019</xref>). These challenges share a common point with those faced by neurons in many neurodegenerative diseases or stroke for which activation of σ1R revealed beneficial effects (<xref ref-type="bibr" rid="B28">Chu and Ruoho, 2016</xref>; <xref ref-type="bibr" rid="B204">Weng et al., 2017</xref>; <xref ref-type="bibr" rid="B128">Penke et al., 2018</xref>; <xref ref-type="bibr" rid="B175">Smith et al., 2018</xref>). The review of studies exploring the function of σ1R in cancers indicates that the protein is generally associated with enhanced invasive properties of cancer cells and a poorer diagnosis at the patient level. In fact, depending on the type of cancer considered, σ1R participates to many hallmark of cancers as defined by <xref ref-type="bibr" rid="B56">Hanahan and Weinberg (2011)</xref>, including apoptosis resistance, migration, invasive potency, angiogenesis and cell response to the microenvironment. The contribution of σ1R to these hallmarks can be synthesized as follows:</p>
<p>σ1R expression lowers <bold>cell sensitivity to apoptosis</bold> by slowing activation of VRAC channels involved in AVD, but no drastically enough to impede RVD, the latter being required for cell cycle progression (<xref ref-type="bibr" rid="B148">Renaudo et al., 2004</xref>, <xref ref-type="bibr" rid="B147">2007</xref>) (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<p>Enhanced <bold>migration</bold> in BC and CRC cancers is the consequence of a σ1R-dependent formation of the special coupling between a Ca<sup>2+</sup>-dependent channel (SK3) and a Ca<sup>2+</sup> channel (Orai1) responsible for increased constitutive or capacitive Ca<sup>2+</sup> entry, which finally triggers cell motility (<xref ref-type="bibr" rid="B55">Guéguinou et al., 2016</xref>; <xref ref-type="bibr" rid="B54">Gueguinou et al., 2017</xref>). In BC cells, σ1R expression increases Na<sub><italic>v</italic></sub>1.5 current density, probably through a direct association between the two proteins (<xref ref-type="bibr" rid="B10">Balasuriya et al., 2012</xref>). Since a Na<sub><italic>v</italic></sub>1.5-associated Na<sup>+</sup> window current stimulates NHE1 activity and subsequent extracellular acidification, σ1R likely potentiates <bold>cell invasiveness potency</bold> through increased Na<sub><italic>v</italic></sub>1.5 activity (<xref ref-type="bibr" rid="B151">Roger et al., 2003</xref>, <xref ref-type="bibr" rid="B153">2004</xref>, <xref ref-type="bibr" rid="B152">2015</xref>; <xref ref-type="bibr" rid="B18">Brisson et al., 2011</xref>, <xref ref-type="bibr" rid="B17">2013</xref>) (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<p>σ1R also deeply influences <bold>the dialog between tumor cells and the microenvironment</bold> by regulating ion channels. By shaping cancer cell electrical signature in response to ECM, σ1R orchestrates the formation of [channel:receptor] complexes at the plasma membrane, contributing to the integration of signals from the tumor microenvironment and the subsequent adaptive phenotype. Indeed, σ1R is a key actor of the formation of [integrin:hERG] signaling hub at the plasma membrane, triggering AKT-dependent pro-metastatic cell behavior <italic>in vivo</italic> by stimulating <bold>migration</bold>, vascular endothelial vascular factor (VEGF) secretion, finally leading to migration, <bold>extravasation</bold> and <bold>angiogenesis</bold> in chronic myeloid leukemia and CRC (<xref ref-type="bibr" rid="B33">Crottès et al., 2016</xref>; <xref ref-type="bibr" rid="B13">Becchetti et al., 2019</xref>) (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<p>Altogether, these results support the idea that the innate function of σ1R, aimed at a better cell survival in physiopathological conditions (<xref ref-type="bibr" rid="B61">Hayashi and Su, 2007</xref>; <xref ref-type="bibr" rid="B28">Chu and Ruoho, 2016</xref>), is hijacked to the benefit of tumor cell growth and invasive properties. It is therefore tempting to postulate that within cancer tissues, σ1R shapes tumor cell electrical signature (<xref ref-type="fig" rid="F1">Figure 1B</xref>), thereby enhancing their adaptation potency to their environment.</p>
</sec>
</sec>
<sec id="S5">
<title>Concluding Remarks</title>
<p>The comprehension of the physiological significance of σ1R as well as the cellular and molecular mechanisms associated with this protein has deeply progressed during the past 10 years. The data accumulated describing the functional interactions between ion channels and σ1R have refined the picture of the contribution of σ1R to CNS diseases including stimulant addiction. The recent data described above demonstrate that contribution to hallmarks of cancer cells and stimulant addiction represent two groups of pathological contexts where [σ1R:ion channel] complexes may play central roles. One of the most striking finding supporting this idea is that a common mechanism, i.e., the chaperoning of voltage-gated K<sup>+</sup> channels, is involved in both neuronal response to cocaine and cancer cell response to tumor microenvironment. In a unifying view, it is tempting to speculate that both cocaine exposure (<xref ref-type="fig" rid="F1">Figure 1A</xref>) and oncogenic processes (<xref ref-type="fig" rid="F1">Figure 1B</xref>) activate the protective function of σ1R that in turn contributes to a shift in cell homeostasis leading to deleterious behaviors.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>OS and SK contributed to all sections in the review. OS and SK were entirely responsible for the sections related to cancer and drug addiction, respectively.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> OS is supported by the Fondation ARC (N°PJA20161204740 and PJA20181207701), Fondation de France (FdF Eotp 535412), and Cancéropôle PACA. SK is supported by a grant from the National Institutes of Health (National Institute on Drug Abuse R01DA041390), the Université du Quebec à Montreal (UQAM), and by the Natural Sciences and Engineering Research Council of Canada (NSERC) (funding reference number RGPIN-2019-06666). SK is a <italic>Fonds de la Recherche du Québec - Santé</italic> (FRQS) Senior Research Scholar.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>M. J.</given-names></name><name><surname>Fleming</surname><given-names>K. L.</given-names></name><name><surname>Raymond</surname><given-names>S.</given-names></name><name><surname>Wong</surname><given-names>A. Y. C.</given-names></name><name><surname>Bergeron</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>The sigma-1 receptor behaves as an atypical auxiliary subunit to modulate the functional characteristics of Kv1.2 channels expressed in <italic>HEK</italic>293 cells.</article-title>
<source/><italic>Physiol. Rep.</italic>
<volume>7</volume>:<issue>e14147</issue>. <pub-id pub-id-type="doi">10.14814/phy2.14147</pub-id>
<pub-id pub-id-type="pmid">31222975</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allahtavakoli</surname><given-names>M.</given-names></name><name><surname>Jarrott</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>85</volume>
<fpage>219</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.03.019</pub-id>
<pub-id pub-id-type="pmid">21453760</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>S. M.</given-names></name><name><surname>Famous</surname><given-names>K. R.</given-names></name><name><surname>Sadri-Vakili</surname><given-names>G.</given-names></name><name><surname>Kumaresan</surname><given-names>V.</given-names></name><name><surname>Schmidt</surname><given-names>H. D.</given-names></name><name><surname>Bass</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>11</volume>
<fpage>344</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1038/nn2054</pub-id>
<pub-id pub-id-type="pmid">18278040</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Serotonergic regulation of neuronal excitability in the prefrontal cortex.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>61</volume>
<fpage>382</fpage>–<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.01.015</pub-id>
<pub-id pub-id-type="pmid">21251917</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcangeli</surname><given-names>A.</given-names></name><name><surname>Becchetti</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>hERG channels: from antitargets to novel targets for cancer therapy.</article-title>
<source/><italic>Clin. Cancer Res.</italic>
<volume>23</volume>
<fpage>3</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-2322</pub-id>
<pub-id pub-id-type="pmid">27903676</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arikkath</surname><given-names>J.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2003</year>). <article-title>Auxiliary subunits: essential components of the voltage-gated calcium channel complex.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>13</volume>
<fpage>298</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="pmid">12850214</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydar</surname><given-names>E.</given-names></name><name><surname>Palmer</surname><given-names>C. P.</given-names></name><name><surname>Klyachko</surname><given-names>V. A.</given-names></name><name><surname>Jackson</surname><given-names>M. B.</given-names></name></person-group> (<year>2002</year>). <article-title>The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.</article-title>
<source/><italic>Neuron</italic>
<volume>34</volume>
<fpage>399</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="pmid">11988171</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydar</surname><given-names>E.</given-names></name><name><surname>Stratton</surname><given-names>D.</given-names></name><name><surname>Fraser</surname><given-names>S. P.</given-names></name><name><surname>Djamgoz</surname><given-names>M. B.</given-names></name><name><surname>Palmer</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Sigma-1 receptors modulate neonatal na.</article-title>
<source/><italic>Eur. Biophys. J.</italic>
<volume>45</volume>
<fpage>671</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="pmid">27160185</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasuriya</surname><given-names>D.</given-names></name><name><surname>D’Sa</surname><given-names>L.</given-names></name><name><surname>Talker</surname><given-names>R.</given-names></name><name><surname>Dupuis</surname><given-names>E.</given-names></name><name><surname>Maurin</surname><given-names>F.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF(R)).</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>32353</fpage>–<lpage>32363</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.603506</pub-id>
<pub-id pub-id-type="pmid">25266722</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasuriya</surname><given-names>D.</given-names></name><name><surname>Stewart</surname><given-names>A. P.</given-names></name><name><surname>Crottes</surname><given-names>D.</given-names></name><name><surname>Borgese</surname><given-names>F.</given-names></name><name><surname>Soriani</surname><given-names>O.</given-names></name><name><surname>Edwardson</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The sigma-1 receptor binds to the Nav1.5 voltage-gated Na+ channel with 4-fold symmetry.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>37021</fpage>–<lpage>37029</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.382077</pub-id>
<pub-id pub-id-type="pmid">22952230</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasuriya</surname><given-names>D.</given-names></name><name><surname>Stewart</surname><given-names>A. P.</given-names></name><name><surname>Edwardson</surname><given-names>J. M.</given-names></name></person-group> (<year>2013</year>). <article-title>The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>18219</fpage>–<lpage>18224</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3360-13.2013</pub-id>
<pub-id pub-id-type="pmid">24227730</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartschat</surname><given-names>D. K.</given-names></name><name><surname>Blaustein</surname><given-names>M. P.</given-names></name></person-group> (<year>1988</year>). <article-title>Psychotomimetic sigma-ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>403</volume>
<fpage>341</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="pmid">3253423</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becchetti</surname><given-names>A.</given-names></name><name><surname>Petroni</surname><given-names>G.</given-names></name><name><surname>Arcangeli</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Ion channel conformations regulate integrin-dependent signaling.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>29</volume>
<fpage>298</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2018.12.005</pub-id>
<pub-id pub-id-type="pmid">30635161</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Calvo</surname><given-names>E.</given-names></name><name><surname>Rivera</surname><given-names>P.</given-names></name><name><surname>Arrabal</surname><given-names>S.</given-names></name><name><surname>Vargas</surname><given-names>A.</given-names></name><name><surname>Pavon</surname><given-names>F. J.</given-names></name><name><surname>Serrano</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat.</article-title>
<source/><italic>Front. Integrat. Neurosci.</italic>
<volume>7</volume>:<issue>106</issue>. <pub-id pub-id-type="doi">10.3389/fnint.2013.00106</pub-id>
<pub-id pub-id-type="pmid">24409127</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bol’shakova</surname><given-names>A. V.</given-names></name><name><surname>Kraskovskaya</surname><given-names>N. A.</given-names></name><name><surname>Gainullina</surname><given-names>A. N.</given-names></name><name><surname>Kukanova</surname><given-names>E. O.</given-names></name><name><surname>Vlasova</surname><given-names>O. L.</given-names></name><name><surname>Bezprozvanny</surname><given-names>I. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroprotective effect of sigma1-receptors on the cell model of huntington’s disease.</article-title>
<source/><italic>Bull. Exp. Biol. Med.</italic>
<volume>164</volume>
<fpage>252</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/s10517-017-3968-7</pub-id>
<pub-id pub-id-type="pmid">29177899</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brent</surname><given-names>P. J.</given-names></name><name><surname>Herd</surname><given-names>L.</given-names></name><name><surname>Saunders</surname><given-names>H.</given-names></name><name><surname>Sim</surname><given-names>A. T.</given-names></name><name><surname>Dunkley</surname><given-names>P. R.</given-names></name></person-group> (<year>1997</year>). <article-title>Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: modulation by the sigma ligand, 1,3-ditolylguanidine.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>68</volume>
<fpage>2201</fpage>–<lpage>2211</lpage>. <pub-id pub-id-type="pmid">9109549</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brisson</surname><given-names>L.</given-names></name><name><surname>Driffort</surname><given-names>V.</given-names></name><name><surname>Benoist</surname><given-names>L.</given-names></name><name><surname>Poet</surname><given-names>M.</given-names></name><name><surname>Counillon</surname><given-names>L.</given-names></name><name><surname>Antelmi</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>NaV1.5 <italic>Na</italic><sup>+2</sup> channels allosterically regulate the <italic>NHE-</italic>1 exchanger and promote the activity of breast cancer cell invadopodia.</article-title>
<source/><italic>J. Cell. Sci.</italic>
<volume>126</volume>
<fpage>4835</fpage>–<lpage>4842</lpage>.<pub-id pub-id-type="pmid">23902689</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brisson</surname><given-names>L.</given-names></name><name><surname>Gillet</surname><given-names>L.</given-names></name><name><surname>Calaghan</surname><given-names>S.</given-names></name><name><surname>Besson</surname><given-names>P.</given-names></name><name><surname>Le Guennec</surname><given-names>J. Y.</given-names></name><name><surname>Roger</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae.</article-title>
<source/><italic>Oncogene</italic>
<volume>30</volume>
<fpage>2070</fpage>–<lpage>2076</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2010.574</pub-id>
<pub-id pub-id-type="pmid">21170089</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Niu</surname><given-names>F.</given-names></name><name><surname>Liao</surname><given-names>K.</given-names></name><name><surname>Buch</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of sigma-1 receptor in cocaine abuse and neurodegenerative disease.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>964</volume>
<fpage>163</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-50174-1_12</pub-id>
<pub-id pub-id-type="pmid">28315271</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calhoun</surname><given-names>J. D.</given-names></name><name><surname>Isom</surname><given-names>L. L.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of non-pore-forming beta subunits in physiology and pathophysiology of voltage-gated sodium channels.</article-title>
<source/><italic>Handb. Exp. Pharmacol.</italic>
<volume>221</volume>
<fpage>51</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-41588-3_4</pub-id>
<pub-id pub-id-type="pmid">24737232</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capriles</surname><given-names>N.</given-names></name><name><surname>Rodaros</surname><given-names>D.</given-names></name><name><surname>Sorge</surname><given-names>R. E.</given-names></name><name><surname>Stewart</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>168</volume>
<fpage>66</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">12442201</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnally</surname><given-names>S. M.</given-names></name><name><surname>Johannessen</surname><given-names>M.</given-names></name><name><surname>Henderson</surname><given-names>R. M.</given-names></name><name><surname>Jackson</surname><given-names>M. B.</given-names></name><name><surname>Edwardson</surname><given-names>J. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>98</volume>
<fpage>1182</fpage>–<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2009.12.4293</pub-id>
<pub-id pub-id-type="pmid">20371317</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Signaling complexes of voltage-gated sodium and calcium channels.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>486</volume>
<fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.08.085</pub-id>
<pub-id pub-id-type="pmid">20816922</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chantôme</surname><given-names>A.</given-names></name><name><surname>Potier-Cartereau</surname><given-names>M.</given-names></name><name><surname>Clarysse</surname><given-names>L.</given-names></name><name><surname>Fromont</surname><given-names>G.</given-names></name><name><surname>Marionneau-Lambot</surname><given-names>S.</given-names></name><name><surname>Guéguinou</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>73</volume>
<fpage>4852</fpage>–<lpage>4861</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-4572</pub-id>
<pub-id pub-id-type="pmid">23774210</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Hajipour</surname><given-names>A. R.</given-names></name><name><surname>Sievert</surname><given-names>M. K.</given-names></name><name><surname>Arbabian</surname><given-names>M.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Characterization of the cocaine binding site on the sigma-1 receptor.</article-title>
<source/><italic>Biochemistry</italic>
<volume>46</volume>
<fpage>3532</fpage>–<lpage>3542</lpage>. <pub-id pub-id-type="pmid">17315983</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. H.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name><name><surname>Lin</surname><given-names>P. L.</given-names></name><name><surname>Tsai</surname><given-names>M. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Cocaine elicits action potential bursts in a central snail neuron: the role of delayed rectifying K+ current.</article-title>
<source/><italic>Neuroscience</italic>
<volume>138</volume>
<fpage>257</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="pmid">16377093</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevallier</surname><given-names>N.</given-names></name><name><surname>Keller</surname><given-names>E.</given-names></name><name><surname>Maurice</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Behavioural phenotyping of knockout mice for the sigma-1 (sigma(1)) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations.</article-title>
<source/><italic>J. Psychopharmacol.</italic>
<volume>25</volume>
<fpage>960</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1177/0269881111400648</pub-id>
<pub-id pub-id-type="pmid">21555330</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>U. B.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Biochemical pharmacology of the sigma-1 receptor.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>89</volume>
<fpage>142</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1124/mol.115.101170</pub-id>
<pub-id pub-id-type="pmid">26560551</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Church</surname><given-names>J.</given-names></name><name><surname>Fletcher</surname><given-names>E. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>116</volume>
<fpage>2801</fpage>–<lpage>2810</lpage>. <pub-id pub-id-type="pmid">8680709</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciranna</surname><given-names>L.</given-names></name><name><surname>Catania</surname><given-names>M. V.</given-names></name></person-group> (<year>2014</year>). <article-title>5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>250</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00250</pub-id>
<pub-id pub-id-type="pmid">25221471</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crottès</surname><given-names>D.</given-names></name><name><surname>Guizouarn</surname><given-names>H.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Borgese</surname><given-names>F.</given-names></name><name><surname>Soriani</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>The sigma-1 receptor: a regulator of cancer cell electrical plasticity?</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>4</volume>:<issue>175</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2013.00175</pub-id>
<pub-id pub-id-type="pmid">23882221</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crottès</surname><given-names>D.</given-names></name><name><surname>Martial</surname><given-names>S.</given-names></name><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name><name><surname>Pisani</surname><given-names>D. F.</given-names></name><name><surname>Loriol</surname><given-names>C.</given-names></name><name><surname>Pellissier</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>27947</fpage>–<lpage>27958</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.226738</pub-id>
<pub-id pub-id-type="pmid">21680736</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crottès</surname><given-names>D.</given-names></name><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name><name><surname>Alcaraz-Perez</surname><given-names>F.</given-names></name><name><surname>Tichet</surname><given-names>M.</given-names></name><name><surname>Gariano</surname><given-names>G.</given-names></name><name><surname>Martial</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>SIGMAR1 regulates membrane electrical activity in response to extracellular matrix stimulation to drive cancer cell invasiveness.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>76</volume>
<fpage>607</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-1465</pub-id>
<pub-id pub-id-type="pmid">26645564</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuevas</surname><given-names>J.</given-names></name><name><surname>Behensky</surname><given-names>A.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Katnik</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>339</volume>
<fpage>152</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.111.182774</pub-id>
<pub-id pub-id-type="pmid">21715562</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delint-Ramirez</surname><given-names>I.</given-names></name><name><surname>Garcia-Oscos</surname><given-names>F.</given-names></name><name><surname>Segev</surname><given-names>A.</given-names></name><name><surname>Kourrich</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Cocaine engages a non-canonical, dopamine-independent, mechanism that controls neuronal excitability in the nucleus accumbens.</article-title>
<source/><italic>Mol. Psychiatr.</italic>
<pub-id pub-id-type="doi">10.1038/s41380-018-0092-7</pub-id>
<pub-id pub-id-type="pmid">29880884</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Chiara</surname><given-names>G.</given-names></name><name><surname>Imperato</surname><given-names>A.</given-names></name></person-group> (<year>1988</year>). <article-title>Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>85</volume>
<fpage>5274</fpage>–<lpage>5278</lpage>. <pub-id pub-id-type="pmid">2899326</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>J. B.</given-names></name><name><surname>Mangeol</surname><given-names>A.</given-names></name><name><surname>Revel</surname><given-names>M. O.</given-names></name><name><surname>Burgun</surname><given-names>C.</given-names></name><name><surname>Aunis</surname><given-names>D.</given-names></name><name><surname>Zwiller</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>48</volume>
<fpage>965</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="pmid">15857623</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Calcium channel diversity: multiple roles of calcium channel subunits.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>19</volume>
<fpage>237</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2009.06.006</pub-id>
<pub-id pub-id-type="pmid">19559597</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>L. Y.</given-names></name><name><surname>Cheng</surname><given-names>Z. X.</given-names></name><name><surname>Fu</surname><given-names>Y. M.</given-names></name><name><surname>Wang</surname><given-names>Z. M.</given-names></name><name><surname>Zhu</surname><given-names>Y. H.</given-names></name><name><surname>Sun</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>52</volume>
<fpage>966</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="pmid">17141281</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Green</surname><given-names>T.</given-names></name><name><surname>Saal</surname><given-names>D.</given-names></name><name><surname>Marie</surname><given-names>H.</given-names></name><name><surname>Neve</surname><given-names>R.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>CREB modulates excitability of nucleus accumbens neurons.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>475</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="pmid">16520736</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The neural rejuvenation hypothesis of cocaine addiction.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>35</volume>
<fpage>374</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2014.05.005</pub-id>
<pub-id pub-id-type="pmid">24958329</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entrena</surname><given-names>J. M.</given-names></name><name><surname>Cobos</surname><given-names>E. J.</given-names></name><name><surname>Nieto</surname><given-names>F. R.</given-names></name><name><surname>Cendan</surname><given-names>C. M.</given-names></name><name><surname>Gris</surname><given-names>G.</given-names></name><name><surname>Del Pozo</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice.</article-title>
<source/><italic>Pain</italic>
<volume>143</volume>
<fpage>252</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2009.03.011</pub-id>
<pub-id pub-id-type="pmid">19375855</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobedo</surname><given-names>L. G.</given-names></name><name><surname>Ruttenber</surname><given-names>A. J.</given-names></name><name><surname>Agocs</surname><given-names>M. M.</given-names></name><name><surname>Anda</surname><given-names>R. F.</given-names></name><name><surname>Wetli</surname><given-names>C. V.</given-names></name></person-group> (<year>1991</year>). <article-title>Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in dade county. florida.</article-title>
<source/><italic>Arch. Pathol. Laborator. Med.</italic>
<volume>115</volume>
<fpage>900</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="pmid">1929786</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrario</surname><given-names>C. R.</given-names></name><name><surname>Gorny</surname><given-names>G.</given-names></name><name><surname>Crombag</surname><given-names>H. S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kolb</surname><given-names>B.</given-names></name><name><surname>Robinson</surname><given-names>T. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>58</volume>
<fpage>751</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="pmid">16098484</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fishback</surname><given-names>J. A.</given-names></name><name><surname>Robson</surname><given-names>M. J.</given-names></name><name><surname>Xu</surname><given-names>Y. T.</given-names></name><name><surname>Matsumoto</surname><given-names>R. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Sigma receptors: potential targets for a new class of antidepressant drug.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>127</volume>
<fpage>271</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2010.04.003</pub-id>
<pub-id pub-id-type="pmid">20438757</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontanilla</surname><given-names>D.</given-names></name><name><surname>Johannessen</surname><given-names>M.</given-names></name><name><surname>Hajipour</surname><given-names>A. R.</given-names></name><name><surname>Cozzi</surname><given-names>N. V.</given-names></name><name><surname>Jackson</surname><given-names>M. B.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>2009</year>). <article-title>The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.</article-title>
<source/><italic>Science</italic>
<volume>323</volume>
<fpage>934</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1126/science.1166127</pub-id>
<pub-id pub-id-type="pmid">19213917</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garces-Ramirez</surname><given-names>L.</given-names></name><name><surname>Green</surname><given-names>J. L.</given-names></name><name><surname>Hiranita</surname><given-names>T.</given-names></name><name><surname>Kopajtic</surname><given-names>T. A.</given-names></name><name><surname>Mereu</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>69</volume>
<fpage>208</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.07.026</pub-id>
<pub-id pub-id-type="pmid">20950794</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassmann</surname><given-names>M.</given-names></name><name><surname>Haller</surname><given-names>C.</given-names></name><name><surname>Stoll</surname><given-names>Y.</given-names></name><name><surname>Abdel Aziz</surname><given-names>S.</given-names></name><name><surname>Biermann</surname><given-names>B.</given-names></name><name><surname>Mosbacher</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The RXR-type endoplasmic reticulum-retention/retrieval signal of GABAB1 requires distant spacing from the membrane to function.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>68</volume>
<fpage>137</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="pmid">15805225</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giese</surname><given-names>K. P.</given-names></name><name><surname>Storm</surname><given-names>J. F.</given-names></name><name><surname>Reuter</surname><given-names>D.</given-names></name><name><surname>Fedorov</surname><given-names>N. B.</given-names></name><name><surname>Shao</surname><given-names>L. R.</given-names></name><name><surname>Leicher</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Reduced K+ channel inactivation, spike broadening, and after-hyperpolarization in Kvbeta1.1-deficient mice with impaired learning.</article-title>
<source/><italic>Learn Mem.</italic>
<volume>5</volume>
<fpage>257</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="pmid">10454353</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>S. M.</given-names></name><name><surname>Clark</surname><given-names>M. J.</given-names></name><name><surname>Traynor</surname><given-names>J. R.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name><name><surname>Napier</surname><given-names>T. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>89</volume>
<fpage>113</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.09.001</pub-id>
<pub-id pub-id-type="pmid">25229719</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesmaier</surname><given-names>E.</given-names></name><name><surname>Posod</surname><given-names>A.</given-names></name><name><surname>Gross</surname><given-names>M.</given-names></name><name><surname>Neubauer</surname><given-names>V.</given-names></name><name><surname>Wegleiter</surname><given-names>K.</given-names></name><name><surname>Hermann</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>237</volume>
<fpage>388</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2012.06.030</pub-id>
<pub-id pub-id-type="pmid">22771763</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gromek</surname><given-names>K. A.</given-names></name><name><surname>Suchy</surname><given-names>F. P.</given-names></name><name><surname>Meddaugh</surname><given-names>H. R.</given-names></name><name><surname>Wrobel</surname><given-names>R. L.</given-names></name><name><surname>LaPointe</surname><given-names>L. M.</given-names></name><name><surname>Chu</surname><given-names>U. B.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The oligomeric states of the purified sigma-1 receptor are stabilized by ligands.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>20333</fpage>–<lpage>20344</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.537993</pub-id>
<pub-id pub-id-type="pmid">24847081</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guéguinou</surname><given-names>M.</given-names></name><name><surname>Chantôme</surname><given-names>A.</given-names></name><name><surname>Fromont</surname><given-names>G.</given-names></name><name><surname>Bougnoux</surname><given-names>P.</given-names></name><name><surname>Vandier</surname><given-names>C.</given-names></name><name><surname>Potier-Cartereau</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>KCa and Ca(2+) channels: the complex thought.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1843</volume>
<fpage>2322</fpage>–<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.02.019</pub-id>
<pub-id pub-id-type="pmid">24613282</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueguinou</surname><given-names>M.</given-names></name><name><surname>Crottès</surname><given-names>D.</given-names></name><name><surname>Chantôme</surname><given-names>A.</given-names></name><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name><name><surname>Potier-Cartereau</surname><given-names>M.</given-names></name><name><surname>Clarysse</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca.</article-title>
<source/><italic>Oncogene</italic>
<volume>36</volume>
<fpage>3640</fpage>–<lpage>3647</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2016.501</pub-id>
<pub-id pub-id-type="pmid">28114279</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guéguinou</surname><given-names>M.</given-names></name><name><surname>Harnois</surname><given-names>T.</given-names></name><name><surname>Crottes</surname><given-names>D.</given-names></name><name><surname>Uguen</surname><given-names>A.</given-names></name><name><surname>Deliot</surname><given-names>N.</given-names></name><name><surname>Gambade</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline.</article-title>
<source/><italic>Oncotarget</italic>
<volume>7</volume>
<fpage>36168</fpage>–<lpage>36184</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8786</pub-id>
<pub-id pub-id-type="pmid">27102434</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation.</article-title>
<source/><italic>Cell</italic>
<volume>144</volume>
<fpage>646</fpage>–<lpage>674</lpage>.<pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Maurice</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2000</year>). <article-title>Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>293</volume>
<fpage>788</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="pmid">10869377</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulating ankyrin dynamics: roles of sigma-1 receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>98</volume>
<fpage>491</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="pmid">11149946</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2003a</year>). <article-title>Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>306</volume>
<fpage>726</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="pmid">12730356</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2003b</year>). <article-title>Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>306</volume>
<fpage>718</fpage>–<lpage>725</lpage>. <pub-id pub-id-type="pmid">12730355</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.</article-title>
<source/><italic>Cell</italic>
<volume>131</volume>
<fpage>596</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="pmid">17981125</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Tsai</surname><given-names>S. Y.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Fujimoto</surname><given-names>M.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.</article-title>
<source/><italic>Expert Opin. Ther. Targets</italic>
<volume>15</volume>
<fpage>557</fpage>–<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1517/14728222.2011.560837</pub-id>
<pub-id pub-id-type="pmid">21375464</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.-L.</given-names></name><name><surname>Zhang</surname><given-names>C.-L.</given-names></name><name><surname>Gao</surname><given-names>X.-F.</given-names></name><name><surname>Yao</surname><given-names>J.-J.</given-names></name><name><surname>Hu</surname><given-names>C.-L.</given-names></name><name><surname>Mei</surname><given-names>Y.-A.</given-names></name></person-group> (<year>2012</year>). <article-title>Cyproheptadine enhances the <italic>I</italic><sub><italic>K</italic></sub> of mouse cortical neurons through sigma-1 receptor-mediated intracellular signal pathway.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e41303</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0041303</pub-id>
<pub-id pub-id-type="pmid">22844454</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilstedt</surname><given-names>H. A.</given-names></name><name><surname>Burgess</surname><given-names>D. L.</given-names></name><name><surname>Anderson</surname><given-names>A. E.</given-names></name><name><surname>Chedrawi</surname><given-names>A.</given-names></name><name><surname>Tharp</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.</article-title>
<source/><italic>Epilepsia</italic>
<volume>42</volume>
<fpage>1103</fpage>–<lpage>1111</lpage>. <pub-id pub-id-type="pmid">11580756</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>Y.</given-names></name><name><surname>Katnik</surname><given-names>C.</given-names></name><name><surname>Rodriguez</surname><given-names>J. D.</given-names></name><name><surname>Hall</surname><given-names>A. A.</given-names></name><name><surname>Willing</surname><given-names>A.</given-names></name><name><surname>Pennypacker</surname><given-names>K. R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>327</volume>
<fpage>491</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.108.143974</pub-id>
<pub-id pub-id-type="pmid">18723775</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hille</surname><given-names>B.</given-names></name></person-group> (<year>2001</year>). <source/><italic>Ionic Channels of Excitable Membranes</italic>, <edition>3rd Edn</edition>
<publisher-loc>Sunderland, MA</publisher-loc>: <publisher-name>Sinauer Associates</publisher-name>.</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiranita</surname><given-names>T.</given-names></name><name><surname>Mereu</surname><given-names>M.</given-names></name><name><surname>Soto</surname><given-names>P. L.</given-names></name><name><surname>Tanda</surname><given-names>G.</given-names></name><name><surname>Katz</surname><given-names>J. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>38</volume>
<fpage>605</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2012.224</pub-id>
<pub-id pub-id-type="pmid">23187725</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopf</surname><given-names>F. W.</given-names></name><name><surname>Cascini</surname><given-names>M. G.</given-names></name><name><surname>Gordon</surname><given-names>A. S.</given-names></name><name><surname>Diamond</surname><given-names>I.</given-names></name><name><surname>Bonci</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>5079</fpage>–<lpage>5087</lpage>. <pub-id pub-id-type="pmid">12832531</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X. T.</given-names></name><name><surname>Basu</surname><given-names>S.</given-names></name><name><surname>White</surname><given-names>F. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Repeated cocaine administration suppresses HVA-Ca2+ potentials and enhances activity of K+ channels in rat nucleus accumbens neurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>92</volume>
<fpage>1597</fpage>–<lpage>1607</lpage>. <pub-id pub-id-type="pmid">15331648</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Jan</surname><given-names>L. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Targeting potassium channels in cancer.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>206</volume>
<fpage>151</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">25049269</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Mu</surname><given-names>P.</given-names></name><name><surname>Moyer</surname><given-names>J. T.</given-names></name><name><surname>Wolf</surname><given-names>J. A.</given-names></name><name><surname>Quock</surname><given-names>R. M.</given-names></name><name><surname>Davies</surname><given-names>N. M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Homeostatic synapse-driven membrane plasticity in nucleus accumbens neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>5820</fpage>–<lpage>5831</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5703-08.2009</pub-id>
<pub-id pub-id-type="pmid">19420249</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>E. Y.</given-names></name><name><surname>Ryu</surname><given-names>Y. H.</given-names></name><name><surname>Lee</surname><given-names>B. H.</given-names></name><name><surname>Chang</surname><given-names>S. C.</given-names></name><name><surname>Yeo</surname><given-names>M. J.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Involvement of reactive oxygen species in cocaine-taking behaviors in rats.</article-title>
<source/><italic>Addict. Biol.</italic>
<volume>20</volume>
<fpage>663</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1111/adb.12159</pub-id>
<pub-id pub-id-type="pmid">24975938</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J. L.</given-names></name><name><surname>Fang</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Y. X.</given-names></name><name><surname>Liu</surname><given-names>X. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Roles of sigma-1 receptors in Alzheimer’s disease.</article-title>
<source/><italic>Int. J. Clin. Exp. Med.</italic>
<volume>8</volume>
<fpage>4808</fpage>–<lpage>4820</lpage>. <pub-id pub-id-type="pmid">26131055</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johannessen</surname><given-names>M.</given-names></name><name><surname>Ramachandran</surname><given-names>S.</given-names></name><name><surname>Riemer</surname><given-names>L.</given-names></name><name><surname>Ramos-Serrano</surname><given-names>A.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name><name><surname>Jackson</surname><given-names>M. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems.</article-title>
<source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>296</volume>
<fpage>C1049</fpage>–<lpage>C1057</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00431.2008</pub-id>
<pub-id pub-id-type="pmid">19279232</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahoun</surname><given-names>J. R.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>1992</year>). <article-title>(125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>89</volume>
<fpage>1393</fpage>–<lpage>1397</lpage>. <pub-id pub-id-type="pmid">1311097</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalivas</surname><given-names>P. W.</given-names></name><name><surname>O’Brien</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Drug addiction as a pathology of staged neuroplasticity.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>166</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="pmid">17805308</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katnik</surname><given-names>C.</given-names></name><name><surname>Guerrero</surname><given-names>W. R.</given-names></name><name><surname>Pennypacker</surname><given-names>K. R.</given-names></name><name><surname>Herrera</surname><given-names>Y.</given-names></name><name><surname>Cuevas</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>319</volume>
<fpage>1355</fpage>–<lpage>1365</lpage>. <pub-id pub-id-type="pmid">16988055</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J. L.</given-names></name><name><surname>Hong</surname><given-names>W. C.</given-names></name><name><surname>Hiranita</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2016</year>). <article-title>A role for sigma receptors in stimulant self-administration and addiction.</article-title>
<source/><italic>Behav. Pharmacol.</italic>
<volume>27</volume>
<fpage>100</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0000000000000209</pub-id>
<pub-id pub-id-type="pmid">26650253</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J. L.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name><name><surname>Hiranita</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Tanda</surname><given-names>G.</given-names></name><name><surname>Kopajtic</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>A role for sigma receptors in stimulant self administration and addiction.</article-title>
<source/><italic>Pharmaceuticals</italic>
<volume>4</volume>
<fpage>880</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="pmid">21904468</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>C.</given-names></name><name><surname>Henderson</surname><given-names>G.</given-names></name></person-group> (<year>1990</year>). <article-title>Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion.</article-title>
<source/><italic>Neuroscience</italic>
<volume>35</volume>
<fpage>725</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="pmid">1974331</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>M.</given-names></name><name><surname>Matsuoka</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Mirrielees</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1452</volume>
<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.02.070</pub-id>
<pub-id pub-id-type="pmid">22433979</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Sigma-1 receptor and neuronal excitability.</article-title>
<source/><italic>Handb. Exp. Pharmacol.</italic>
<volume>244</volume>
<fpage>109</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/164_2017_8</pub-id>
<pub-id pub-id-type="pmid">28275909</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name><name><surname>Calu</surname><given-names>D. J.</given-names></name><name><surname>Bonci</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Intrinsic plasticity: an emerging player in addiction.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>
<fpage>173</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3877</pub-id>
<pub-id pub-id-type="pmid">25697160</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Chuang</surname><given-names>J. Y.</given-names></name><name><surname>Tsai</surname><given-names>S. Y.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name><name><surname>Bonci</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine.</article-title>
<source/><italic>Cell</italic>
<volume>152</volume>
<fpage>236</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.12.004</pub-id>
<pub-id pub-id-type="pmid">23332758</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name><name><surname>Klug</surname><given-names>J. R.</given-names></name><name><surname>Mayford</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>M. J.</given-names></name></person-group> (<year>2012a</year>). <article-title>AMPAR-independent effect of striatal CaMKII promotes the sensitization of cocaine reward.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>6578</fpage>–<lpage>6586</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.6391-1511.2012</pub-id>
<pub-id pub-id-type="pmid">22573680</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name><name><surname>Fujimoto</surname><given-names>M.</given-names></name><name><surname>Bonci</surname><given-names>A.</given-names></name></person-group> (<year>2012b</year>). <article-title>The sigma-1 receptor: roles in neuronal plasticity and disease.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>35</volume>
<fpage>762</fpage>–<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.09.007</pub-id>
<pub-id pub-id-type="pmid">23102998</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname><given-names>S.</given-names></name><name><surname>Thomas</surname><given-names>M. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Similar neurons, opposite adaptations: psychostimulant experience differentially alters firing properties in accumbens core versus shell.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>12275</fpage>–<lpage>12283</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3028-09.2009</pub-id>
<pub-id pub-id-type="pmid">19793986</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuribara</surname><given-names>H.</given-names></name><name><surname>Uchihashi</surname><given-names>Y.</given-names></name></person-group> (<year>1993</year>). <article-title>Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice.</article-title>
<source/><italic>J. Pharm. Pharmacol.</italic>
<volume>45</volume>
<fpage>1042</fpage>–<lpage>1045</lpage>.<pub-id pub-id-type="pmid">7908972</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>I. H.</given-names></name><name><surname>Hoffmann</surname><given-names>E. K.</given-names></name><name><surname>Pedersen</surname><given-names>S. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Cell volume regulation: physiology and pathophysiology.</article-title>
<source/><italic>Acta Physiol.</italic>
<volume>194</volume>
<fpage>255</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.2008.01910.x</pub-id>
<pub-id pub-id-type="pmid">18945273</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langa</surname><given-names>F.</given-names></name><name><surname>Codony</surname><given-names>X.</given-names></name><name><surname>Tovar</surname><given-names>V.</given-names></name><name><surname>Lavado</surname><given-names>A.</given-names></name><name><surname>Gimenez</surname><given-names>E.</given-names></name><name><surname>Cozar</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>18</volume>
<fpage>2188</fpage>–<lpage>2196</lpage>. <pub-id pub-id-type="pmid">14622179</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Pedrajas</surname><given-names>R.</given-names></name><name><surname>Ramirez-Lamelas</surname><given-names>D. T.</given-names></name><name><surname>Muriach</surname><given-names>B.</given-names></name><name><surname>Sanchez-Villarejo</surname><given-names>M. V.</given-names></name><name><surname>Almansa</surname><given-names>I.</given-names></name><name><surname>Vidal-Gil</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cocaine promotes oxidative stress and microglial-macrophage activation in rat cerebellum.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>279</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00279</pub-id>
<pub-id pub-id-type="pmid">26283916</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupardus</surname><given-names>P. J.</given-names></name><name><surname>Wilke</surname><given-names>R. A.</given-names></name><name><surname>Aydar</surname><given-names>E.</given-names></name><name><surname>Palmer</surname><given-names>C. P.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>526</volume>(<issue>Pt 3</issue>), <fpage>527</fpage>–<lpage>539</lpage>. <pub-id pub-id-type="pmid">10922005</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luscher</surname><given-names>C.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling.</article-title>
<source/><italic>Neuron</italic>
<volume>69</volume>
<fpage>650</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.017</pub-id>
<pub-id pub-id-type="pmid">21338877</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luty</surname><given-names>A. A.</given-names></name><name><surname>Kwok</surname><given-names>J. B.</given-names></name><name><surname>Dobson-Stone</surname><given-names>C.</given-names></name><name><surname>Loy</surname><given-names>C. T.</given-names></name><name><surname>Coupland</surname><given-names>K. G.</given-names></name><name><surname>Karlstrom</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>68</volume>
<fpage>639</fpage>–<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22274</pub-id>
<pub-id pub-id-type="pmid">21031579</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeno</surname><given-names>E.</given-names></name><name><surname>Ishizaki</surname><given-names>Y.</given-names></name><name><surname>Kanaseki</surname><given-names>T.</given-names></name><name><surname>Hazama</surname><given-names>A.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name></person-group> (<year>2000</year>). <article-title>Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>97</volume>
<fpage>9487</fpage>–<lpage>9492</lpage>.<pub-id pub-id-type="pmid">10900263</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffie</surname><given-names>J.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Weighing the evidence for a ternary protein complex mediating A-type K+ currents in neurons.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>586</volume>
<fpage>5609</fpage>–<lpage>5623</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2008.161620</pub-id>
<pub-id pub-id-type="pmid">18845608</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionneau</surname><given-names>C.</given-names></name><name><surname>Carrasquillo</surname><given-names>Y.</given-names></name><name><surname>Norris</surname><given-names>A. J.</given-names></name><name><surname>Townsend</surname><given-names>R. R.</given-names></name><name><surname>Isom</surname><given-names>L. L.</given-names></name><name><surname>Link</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The sodium channel accessory subunit Navbeta1 regulates neuronal excitability through modulation of repolarizing voltage-gated K(+) channels.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>5716</fpage>–<lpage>5727</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6450-11.2012</pub-id>
<pub-id pub-id-type="pmid">22539834</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>W. R.</given-names></name><name><surname>Eades</surname><given-names>C. G.</given-names></name><name><surname>Thompson</surname><given-names>J. A.</given-names></name><name><surname>Huppler</surname><given-names>R. E.</given-names></name><name><surname>Gilbert</surname><given-names>P. E.</given-names></name></person-group> (<year>1976</year>). <article-title>The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>197</volume>
<fpage>517</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="pmid">945347</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Espinosa</surname><given-names>P. L.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>V.</given-names></name><name><surname>Xia</surname><given-names>X. M.</given-names></name><name><surname>Lingle</surname><given-names>C. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Knockout of the BK beta2 subunit abolishes inactivation of BK currents in mouse adrenal chromaffin cells and results in slow-wave burst activity.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>144</volume>
<fpage>275</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201411253</pub-id>
<pub-id pub-id-type="pmid">25267913</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattingly</surname><given-names>B. A.</given-names></name><name><surname>Hart</surname><given-names>T. C.</given-names></name><name><surname>Lim</surname><given-names>K.</given-names></name><name><surname>Perkins</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>114</volume>
<fpage>239</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">7838914</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurice</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2009</year>). <article-title>The pharmacology of sigma-1 receptors.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>124</volume>
<fpage>195</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2009.07.001</pub-id>
<pub-id pub-id-type="pmid">19619582</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavlyutov</surname><given-names>T. A.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells.</article-title>
<source/><italic>J. Mol. Signal.</italic>
<volume>2</volume>:<issue>8</issue>. <pub-id pub-id-type="pmid">17883859</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>K.</given-names></name><name><surname>Davidge</surname><given-names>S. B.</given-names></name><name><surname>Lapish</surname><given-names>C. C.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>1551</fpage>–<lpage>1560</lpage>. <pub-id pub-id-type="pmid">14973230</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>K.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2001</year>). <article-title>The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>21</volume>
<fpage>8655</fpage>–<lpage>8663</lpage>. <pub-id pub-id-type="pmid">11606653</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>K.</given-names></name><name><surname>Lapish</surname><given-names>C. C.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>3531</fpage>–<lpage>3537</lpage>. <pub-id pub-id-type="pmid">12716962</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>J.</given-names></name><name><surname>See</surname><given-names>R. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>168</volume>
<fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-002-1196-x</pub-id>
<pub-id pub-id-type="pmid">12845418</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A. K.</given-names></name><name><surname>Mavlyutov</surname><given-names>T.</given-names></name><name><surname>Singh</surname><given-names>D. R.</given-names></name><name><surname>Biener</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Oliver</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>466</volume>
<fpage>263</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20141321</pub-id>
<pub-id pub-id-type="pmid">25510962</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteith</surname><given-names>G. R.</given-names></name><name><surname>Prevarskaya</surname><given-names>N.</given-names></name><name><surname>Roberts-Thomson</surname><given-names>S. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The calcium-cancer signalling nexus.</article-title>
<source/><italic>Nat. Rev. Cancer</italic>
<volume>17</volume>
<fpage>367</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1038/nrc.2017.18</pub-id>
<pub-id pub-id-type="pmid">28386091</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monyer</surname><given-names>H.</given-names></name><name><surname>Burnashev</surname><given-names>N.</given-names></name><name><surname>Laurie</surname><given-names>D. J.</given-names></name><name><surname>Sakmann</surname><given-names>B.</given-names></name><name><surname>Seeburg</surname><given-names>P. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.</article-title>
<source/><italic>Neuron</italic>
<volume>12</volume>
<fpage>529</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="pmid">7512349</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Compromising sigma-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-kappaB/Bcl-2-dependent mechanism: potential relevance to Parkinson’s disease.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>341</volume>
<fpage>663</fpage>–<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.111.190868</pub-id>
<pub-id pub-id-type="pmid">22399814</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriguchi</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Ikuno</surname><given-names>T.</given-names></name><name><surname>Fukunaga</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>117</volume>
<fpage>879</fpage>–<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07256.x</pub-id>
<pub-id pub-id-type="pmid">21434925</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morio</surname><given-names>Y.</given-names></name><name><surname>Tanimoto</surname><given-names>H.</given-names></name><name><surname>Yakushiji</surname><given-names>T.</given-names></name><name><surname>Morimoto</surname><given-names>Y.</given-names></name></person-group> (<year>1994</year>). <article-title>Characterization of the currents induced by sigma ligands in NCB20 neuroblastoma cells.</article-title>
<source/><italic>Brain Res.</italic>
<volume>637</volume>
<fpage>190</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="pmid">7910100</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>P.</given-names></name><name><surname>Moyer</surname><given-names>J. T.</given-names></name><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Panksepp</surname><given-names>J.</given-names></name><name><surname>Sorg</surname><given-names>B. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Exposure to cocaine dynamically regulates the intrinsic membrane excitability of nucleus accumbens neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>3689</fpage>–<lpage>3699</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4063-09.2010</pub-id>
<pub-id pub-id-type="pmid">20220002</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muriach</surname><given-names>M.</given-names></name><name><surname>Lopez-Pedrajas</surname><given-names>R.</given-names></name><name><surname>Barcia</surname><given-names>J. M.</given-names></name><name><surname>Sanchez-Villarejo</surname><given-names>M. V.</given-names></name><name><surname>Almansa</surname><given-names>I.</given-names></name><name><surname>Romero</surname><given-names>F. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>114</volume>
<fpage>675</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06794.x</pub-id>
<pub-id pub-id-type="pmid">20477932</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasif</surname><given-names>F. J.</given-names></name><name><surname>Sidiropoulou</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name><name><surname>White</surname><given-names>F. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Repeated cocaine administration increases membrane excitability of pyramidal neurons in the rat medial prefrontal cortex.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>312</volume>
<fpage>1305</fpage>–<lpage>1313</lpage>. <pub-id pub-id-type="pmid">15574686</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>G.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name><name><surname>Aymerich</surname><given-names>M.</given-names></name><name><surname>Marcellino</surname><given-names>D.</given-names></name><name><surname>McCormick</surname><given-names>P. J.</given-names></name><name><surname>Mallol</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>18676</fpage>–<lpage>18681</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1008911107</pub-id>
<pub-id pub-id-type="pmid">20956312</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>E. C.</given-names></name><name><surname>McCracken</surname><given-names>K. A.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Pouw</surname><given-names>B.</given-names></name><name><surname>Matsumoto</surname><given-names>R. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>49</volume>
<fpage>638</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="pmid">15939443</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>D. E.</given-names></name><name><surname>Nichols</surname><given-names>C. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Serotonin receptors.</article-title>
<source/><italic>Chem. Rev.</italic>
<volume>108</volume>
<fpage>1614</fpage>–<lpage>1641</lpage>.<pub-id pub-id-type="pmid">18476671</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutt</surname><given-names>D. J.</given-names></name><name><surname>Lingford-Hughes</surname><given-names>A.</given-names></name><name><surname>Erritzoe</surname><given-names>D.</given-names></name><name><surname>Stokes</surname><given-names>P. R.</given-names></name></person-group> (<year>2015</year>). <article-title>The dopamine theory of addiction: 40 years of highs and lows.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>
<fpage>305</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3939</pub-id>
<pub-id pub-id-type="pmid">25873042</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obacz</surname><given-names>J.</given-names></name><name><surname>Avril</surname><given-names>T.</given-names></name><name><surname>Rubio-Patiño</surname><given-names>C.</given-names></name><name><surname>Bossowski</surname><given-names>J. P.</given-names></name><name><surname>Igbaria</surname><given-names>A.</given-names></name><name><surname>Ricci</surname><given-names>J. E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Regulation of tumor-stroma interactions by the unfolded protein response.</article-title>
<source/><italic>FEBS J.</italic>
<volume>286</volume>
<fpage>279</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14359</pub-id>
<pub-id pub-id-type="pmid">29239107</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>M. E.</given-names></name><name><surname>Chahine</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>541</volume>
<fpage>701</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="pmid">12068034</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabba</surname><given-names>M.</given-names></name><name><surname>Wong</surname><given-names>A. Y.</given-names></name><name><surname>Ahlskog</surname><given-names>N.</given-names></name><name><surname>Hristova</surname><given-names>E.</given-names></name><name><surname>Biscaro</surname><given-names>D.</given-names></name><name><surname>Nassrallah</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>11325</fpage>–<lpage>11338</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0458-14.2014</pub-id>
<pub-id pub-id-type="pmid">25143613</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paly</surname><given-names>D.</given-names></name><name><surname>Jatlow</surname><given-names>P.</given-names></name><name><surname>Van Dyke</surname><given-names>C.</given-names></name><name><surname>Jeri</surname><given-names>F. R.</given-names></name><name><surname>Byck</surname><given-names>R.</given-names></name></person-group> (<year>1982</year>). <article-title>Plasma cocaine concentrations during cocaine paste smoking.</article-title>
<source/><italic>Life Sci.</italic>
<volume>30</volume>
<fpage>731</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="pmid">7070227</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Kwok</surname><given-names>W. M.</given-names></name><name><surname>Hogan</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>H. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Sigma-1 receptor antagonism restores injury-induced decrease of voltage-gated Ca2+ current in sensory neurons.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>350</volume>
<fpage>290</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.114.214320</pub-id>
<pub-id pub-id-type="pmid">24891452</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaioannou</surname><given-names>A.</given-names></name><name><surname>Higa</surname><given-names>A.</given-names></name><name><surname>Jégou</surname><given-names>G.</given-names></name><name><surname>Jouan</surname><given-names>F.</given-names></name><name><surname>Pineau</surname><given-names>R.</given-names></name><name><surname>Saas</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Alterations of EDEM1 functions enhance ATF6 pro-survival signaling.</article-title>
<source/><italic>FEBS J.</italic>
<volume>285</volume>
<fpage>4146</fpage>–<lpage>4164</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14669</pub-id>
<pub-id pub-id-type="pmid">30281916</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>L. A.</given-names></name><name><surname>Stuhmer</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>The roles of K(+) channels in cancer.</article-title>
<source/><italic>Nat. Rev. Cancer</italic>
<volume>14</volume>
<fpage>39</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">24336491</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pchitskaya</surname><given-names>E.</given-names></name><name><surname>Popugaeva</surname><given-names>E.</given-names></name><name><surname>Bezprozvanny</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Calcium signaling and molecular mechanisms underlying neurodegenerative diseases.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>70</volume>
<fpage>87</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2017.06.008</pub-id>
<pub-id pub-id-type="pmid">28728834</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penke</surname><given-names>B.</given-names></name><name><surname>Fulop</surname><given-names>L.</given-names></name><name><surname>Szucs</surname><given-names>M.</given-names></name><name><surname>Frecska</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases.</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>16</volume>
<fpage>97</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X15666170529104323</pub-id>
<pub-id pub-id-type="pmid">28554311</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peoples</surname><given-names>L. L.</given-names></name><name><surname>Cavanaugh</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>Differential changes in signal and background firing of accumbal neurons during cocaine self-administration.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>90</volume>
<fpage>993</fpage>–<lpage>1010</lpage>. <pub-id pub-id-type="pmid">12904500</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peoples</surname><given-names>L. L.</given-names></name><name><surname>Kravitz</surname><given-names>A. V.</given-names></name><name><surname>Guillem</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>The role of accumbal hypoactivity in cocaine addiction.</article-title>
<source/><italic>Sci. World J.</italic>
<volume>7</volume>
<fpage>22</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="pmid">17982574</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peoples</surname><given-names>L. L.</given-names></name><name><surname>Uzwiak</surname><given-names>A. J.</given-names></name><name><surname>Gee</surname><given-names>F.</given-names></name><name><surname>West</surname><given-names>M. O.</given-names></name></person-group> (<year>1999</year>). <article-title>Tonic firing of rat nucleus accumbens neurons: changes during the first 2 weeks of daily cocaine self-administration sessions.</article-title>
<source/><italic>Brain Res.</italic>
<volume>822</volume>
<fpage>231</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="pmid">10082901</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peoples</surname><given-names>L. L.</given-names></name><name><surname>Uzwiak</surname><given-names>A. J.</given-names></name><name><surname>Guyette</surname><given-names>F. X.</given-names></name><name><surname>West</surname><given-names>M. O.</given-names></name></person-group> (<year>1998</year>). <article-title>Tonic inhibition of single nucleus accumbens neurons in the rat: a predominant but not exclusive firing pattern induced by cocaine self-administration sessions.</article-title>
<source/><italic>Neuroscience</italic>
<volume>86</volume>
<fpage>13</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="pmid">9692739</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>R. B.</given-names></name><name><surname>Andrade</surname><given-names>P. B.</given-names></name><name><surname>Valentao</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>a comprehensive view of the neurotoxicity mechanisms of cocaine and ethanol.</article-title>
<source/><italic>Neuro. Res.</italic>
<volume>28</volume>
<fpage>253</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-015-9536-x</pub-id>
<pub-id pub-id-type="pmid">26105693</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>M. F.</given-names></name><name><surname>White</surname><given-names>F. J.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>96</volume>
<fpage>2217</fpage>–<lpage>2228</lpage>. <pub-id pub-id-type="pmid">16885524</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>J.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name><name><surname>Quirk</surname><given-names>G. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Extinction circuits for fear and addiction overlap in prefrontal cortex.</article-title>
<source/><italic>Learn. Mem.</italic>
<volume>16</volume>
<fpage>279</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1101/lm.1041309</pub-id>
<pub-id pub-id-type="pmid">19380710</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>H. O.</given-names></name><name><surname>Pan</surname><given-names>H. T.</given-names></name><name><surname>Parsons</surname><given-names>L. H.</given-names></name><name><surname>Justice</surname><given-names>J. B.</given-names></name></person-group> (<year>1990</year>). <article-title>Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>55</volume>
<fpage>798</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="pmid">2384752</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phartiyal</surname><given-names>P.</given-names></name><name><surname>Sale</surname><given-names>H.</given-names></name><name><surname>Jones</surname><given-names>E. M.</given-names></name><name><surname>Robertson</surname><given-names>G. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Endoplasmic reticulum retention and rescue by heteromeric assembly regulate human ERG 1a/1b surface channel composition.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>283</volume>
<fpage>3702</fpage>–<lpage>3707</lpage>. <pub-id pub-id-type="pmid">18048364</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piechota</surname><given-names>M.</given-names></name><name><surname>Korostynski</surname><given-names>M.</given-names></name><name><surname>Solecki</surname><given-names>W.</given-names></name><name><surname>Gieryk</surname><given-names>A.</given-names></name><name><surname>Slezak</surname><given-names>M.</given-names></name><name><surname>Bilecki</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>11</volume>:<issue>R48</issue>. <pub-id pub-id-type="doi">10.1186/gb-2010-11-5-r48</pub-id>
<pub-id pub-id-type="pmid">20459597</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pongs</surname><given-names>O.</given-names></name><name><surname>Leicher</surname><given-names>T.</given-names></name><name><surname>Berger</surname><given-names>M.</given-names></name><name><surname>Roeper</surname><given-names>J.</given-names></name><name><surname>Bahring</surname><given-names>R.</given-names></name><name><surname>Wray</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Functional and molecular aspects of voltage-gated K+ channel beta subunits.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>868</volume>
<fpage>344</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="pmid">10414304</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prevarskaya</surname><given-names>N.</given-names></name><name><surname>Skryma</surname><given-names>R.</given-names></name><name><surname>Shuba</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Ion channels and the hallmarks of cancer.</article-title>
<source/><italic>Trends Mol. Med.</italic>
<volume>16</volume>
<fpage>107</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">20167536</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prevarskaya</surname><given-names>N.</given-names></name><name><surname>Skryma</surname><given-names>R.</given-names></name><name><surname>Shuba</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Ion channels in cancer: are cancer hallmarks oncochannelopathies?</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>98</volume>
<fpage>559</fpage>–<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00044.2016</pub-id>
<pub-id pub-id-type="pmid">29412049</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinssen</surname><given-names>E. P.</given-names></name><name><surname>Colpaert</surname><given-names>F. C.</given-names></name><name><surname>Kleven</surname><given-names>M. S.</given-names></name><name><surname>Koek</surname><given-names>W.</given-names></name></person-group> (<year>2004</year>). <article-title>Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>172</volume>
<fpage>409</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="pmid">14668976</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quail</surname><given-names>D. F.</given-names></name><name><surname>Joyce</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Microenvironmental regulation of tumor progression and metastasis.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>19</volume>
<fpage>1423</fpage>–<lpage>1437</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3394</pub-id>
<pub-id pub-id-type="pmid">24202395</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name><name><surname>Borgese</surname><given-names>F.</given-names></name><name><surname>Harvey</surname><given-names>B. J.</given-names></name><name><surname>Soriani</surname><given-names>O.</given-names></name></person-group> (<year>2018</year>). <article-title>[KCNQ1: a new regulator of the epithelio-mesenchymal transition in colorectal cancers].</article-title>
<source/><italic>Med. Sci.</italic>
<volume>34</volume>
<fpage>21</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name><name><surname>Bustos</surname><given-names>V.</given-names></name><name><surname>Thomas</surname><given-names>W.</given-names></name><name><surname>McBryan</surname><given-names>J.</given-names></name><name><surname>Harvey</surname><given-names>H.</given-names></name><name><surname>Lajczak</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>114</volume>
<fpage>4159</fpage>–<lpage>4164</lpage>.<pub-id pub-id-type="pmid">28373572</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reith</surname><given-names>M. E. A.</given-names></name><name><surname>Sershen</surname><given-names>H.</given-names></name><name><surname>Lajtha</surname><given-names>A.</given-names></name></person-group> (<year>1986</year>). <article-title>Binding-sites for [H-3] cocaine in mouse striatum and cerebral-cortex have different dissociation kinetics.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>46</volume>
<fpage>309</fpage>–<lpage>312</lpage>.<pub-id pub-id-type="pmid">3940290</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaudo</surname><given-names>A.</given-names></name><name><surname>L’Hoste</surname><given-names>S.</given-names></name><name><surname>Guizouarn</surname><given-names>H.</given-names></name><name><surname>Borgese</surname><given-names>F.</given-names></name><name><surname>Soriani</surname><given-names>O.</given-names></name></person-group> (<year>2007</year>). <article-title>Cancer cell cycle modulated by a functional coupling between sigma-1 receptors and Cl- channels.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>282</volume>
<fpage>2259</fpage>–<lpage>2267</lpage>. <pub-id pub-id-type="pmid">17121836</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaudo</surname><given-names>A.</given-names></name><name><surname>Watry</surname><given-names>V.</given-names></name><name><surname>Chassot</surname><given-names>A. A.</given-names></name><name><surname>Ponzio</surname><given-names>G.</given-names></name><name><surname>Ehrenfeld</surname><given-names>J.</given-names></name><name><surname>Soriani</surname><given-names>O.</given-names></name></person-group> (<year>2004</year>). <article-title>Inhibition of tumor cell proliferation by sigma ligands is associated with K+ Channel inhibition and p27kip1 accumulation.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>311</volume>
<fpage>1105</fpage>–<lpage>1114</lpage>. <pub-id pub-id-type="pmid">15277583</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renthal</surname><given-names>W.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name><name><surname>Wilkinson</surname><given-names>M.</given-names></name><name><surname>Covington</surname><given-names>H. E.</given-names><suffix>III</suffix></name><name><surname>Maze</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins.</article-title>
<source/><italic>Neuron</italic>
<volume>62</volume>
<fpage>335</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.026</pub-id>
<pub-id pub-id-type="pmid">19447090</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>T. E.</given-names></name><name><surname>Berridge</surname><given-names>K. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Review. The incentive sensitization theory of addiction: some current issues.</article-title>
<source/><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic>
<volume>363</volume>
<fpage>3137</fpage>–<lpage>3146</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2008.0093</pub-id>
<pub-id pub-id-type="pmid">18640920</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>S.</given-names></name><name><surname>Besson</surname><given-names>P.</given-names></name><name><surname>Le Guennec</surname><given-names>J. Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1616</volume>
<fpage>107</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="pmid">14561467</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>S.</given-names></name><name><surname>Gillet</surname><given-names>L.</given-names></name><name><surname>Le Guennec</surname><given-names>J. Y.</given-names></name><name><surname>Besson</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Voltage-gated sodium channels and cancer: is excitability their primary role?</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>6</volume>:<issue>152</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00152</pub-id>
<pub-id pub-id-type="pmid">26283962</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>S.</given-names></name><name><surname>Le Guennec</surname><given-names>J. Y.</given-names></name><name><surname>Besson</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>141</volume>
<fpage>610</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="pmid">14744811</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>S.</given-names></name><name><surname>Potier</surname><given-names>M.</given-names></name><name><surname>Vandier</surname><given-names>C.</given-names></name><name><surname>Besson</surname><given-names>P.</given-names></name><name><surname>Le Guennec</surname><given-names>J. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Voltage-gated sodium channels: new targets in cancer therapy?</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>12</volume>
<fpage>3681</fpage>–<lpage>3695</lpage>. <pub-id pub-id-type="pmid">17073667</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romieu</surname><given-names>P.</given-names></name><name><surname>Meunier</surname><given-names>J.</given-names></name><name><surname>Garcia</surname><given-names>D.</given-names></name><name><surname>Zozime</surname><given-names>N.</given-names></name><name><surname>Martin-Fardon</surname><given-names>R.</given-names></name><name><surname>Bowen</surname><given-names>W. D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>175</volume>
<fpage>154</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="pmid">14985920</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothman</surname><given-names>R. B.</given-names></name><name><surname>Reid</surname><given-names>A.</given-names></name><name><surname>Mahboubi</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>C. H.</given-names></name><name><surname>De Costa</surname><given-names>B. R.</given-names></name><name><surname>Jacobson</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>1991</year>). <article-title>Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>39</volume>
<fpage>222</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">1847495</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouzaire-Dubois</surname><given-names>B.</given-names></name><name><surname>Dubois</surname><given-names>J. M.</given-names></name></person-group> (<year>1998</year>). <article-title>K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>510</volume>(<issue>Pt 1</issue>), <fpage>93</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="pmid">9625869</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouzaire-Dubois</surname><given-names>B.</given-names></name><name><surname>Milandri</surname><given-names>J. B.</given-names></name><name><surname>Bostel</surname><given-names>S.</given-names></name><name><surname>Dubois</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Control of cell proliferation by cell volume alterations in rat C6 glioma cells.</article-title>
<source/><italic>Pflugers. Arch.</italic>
<volume>440</volume>
<fpage>881</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="pmid">11041554</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumbaugh</surname><given-names>G.</given-names></name><name><surname>Vicini</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>19</volume>
<fpage>10603</fpage>–<lpage>10610</lpage>. <pub-id pub-id-type="pmid">10594044</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryskamp</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Geva</surname><given-names>M.</given-names></name><name><surname>Kusko</surname><given-names>R.</given-names></name><name><surname>Grossman</surname><given-names>I.</given-names></name><name><surname>Hayden</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of huntington disease.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>97</volume>
<fpage>46</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.10.006</pub-id>
<pub-id pub-id-type="pmid">27818324</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryskamp</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Rammes</surname><given-names>G.</given-names></name><name><surname>Geva</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Pridopidine stabilizes mushroom spines in mouse models of Alzheimer’s disease by acting on the sigma-1 receptor.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>124</volume>
<fpage>489</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2018.12.022</pub-id>
<pub-id pub-id-type="pmid">30594810</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabeti</surname><given-names>J.</given-names></name><name><surname>Nelson</surname><given-names>T. E.</given-names></name><name><surname>Purdy</surname><given-names>R. H.</given-names></name><name><surname>Gruol</surname><given-names>D. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors.</article-title>
<source/><italic>Hippocampus</italic>
<volume>17</volume>
<fpage>349</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="pmid">17330865</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabino</surname><given-names>V.</given-names></name><name><surname>Cottone</surname><given-names>P.</given-names></name><name><surname>Parylak</surname><given-names>S. L.</given-names></name><name><surname>Steardo</surname><given-names>L.</given-names></name><name><surname>Zorrilla</surname><given-names>E. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Sigma-1 receptor knockout mice display a depressive-like phenotype.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>198</volume>
<fpage>472</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2008.11.036</pub-id>
<pub-id pub-id-type="pmid">19100292</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambo</surname><given-names>D. O.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Owens</surname><given-names>A.</given-names></name><name><surname>Lebowitz</surname><given-names>J. J.</given-names></name><name><surname>Richardson</surname><given-names>B.</given-names></name><name><surname>Jagnarine</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>2228</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-02087-x</pub-id>
<pub-id pub-id-type="pmid">29263318</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilstrom</surname><given-names>B.</given-names></name><name><surname>Yaka</surname><given-names>R.</given-names></name><name><surname>Argilli</surname><given-names>E.</given-names></name><name><surname>Suvarna</surname><given-names>N.</given-names></name><name><surname>Schumann</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>B. T.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>8549</fpage>–<lpage>8558</lpage>. <pub-id pub-id-type="pmid">16914681</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>H. R.</given-names></name><name><surname>Kruse</surname><given-names>A. C.</given-names></name></person-group> (<year>2019</year>). <article-title>The molecular function of sigma receptors: past, present, and future.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>40</volume>
<fpage>636</fpage>–<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2019.07.006</pub-id>
<pub-id pub-id-type="pmid">31387763</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>H. R.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Gurpinar</surname><given-names>E.</given-names></name><name><surname>Koehl</surname><given-names>A.</given-names></name><name><surname>Manglik</surname><given-names>A.</given-names></name><name><surname>Kruse</surname><given-names>A. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Crystal structure of the human sigma1 receptor.</article-title>
<source/><italic>Nature</italic>
<volume>532</volume>
<fpage>527</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1038/nature17391</pub-id>
<pub-id pub-id-type="pmid">27042935</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze-Bahr</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wedekind</surname><given-names>H.</given-names></name><name><surname>Haverkamp</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>KCNE1 mutations cause jervell and lange-nielsen syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>17</volume>
<fpage>267</fpage>–<lpage>268</lpage>.<pub-id pub-id-type="pmid">9354783</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>D. B.</given-names></name><name><surname>Blanpied</surname><given-names>T. A.</given-names></name><name><surname>Ehlers</surname><given-names>M. D.</given-names></name></person-group> (<year>2003</year>). <article-title>Coordinated PKA and PKC phosphorylation suppresses RXR-mediated ER retention and regulates the surface delivery of NMDA receptors.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>45</volume>
<fpage>755</fpage>–<lpage>767</lpage>. <pub-id pub-id-type="pmid">14529714</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segev</surname><given-names>A.</given-names></name><name><surname>Delint-Ramirez</surname><given-names>I.</given-names></name><name><surname>Kourrich</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Contingent versus non-contingent cocaine administration differentially affects the persistence of neuronal intrinsic plasticity of medium spiny neurons in the nucleus accumbens shell.</article-title>
<source/><italic>Soc. Neurosci. Abstract</italic>
<comment>419.17</comment>.</mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergeant</surname><given-names>G. P.</given-names></name><name><surname>Ohya</surname><given-names>S.</given-names></name><name><surname>Reihill</surname><given-names>J. A.</given-names></name><name><surname>Perrino</surname><given-names>B. A.</given-names></name><name><surname>Amberg</surname><given-names>G. C.</given-names></name><name><surname>Imaizumi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Regulation of Kv4.3 currents by <italic>Ca</italic>2+/calmodulin-dependent protein kinase II.</article-title>
<source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>288</volume>
<fpage>C304</fpage>–<lpage>C313</lpage>. <pub-id pub-id-type="pmid">15456698</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>J.</given-names></name><name><surname>Glen</surname><given-names>K. A.</given-names></name><name><surname>Wolfe</surname><given-names>S.</given-names></name><name><surname>Kuhar</surname><given-names>M. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Cocaine binding at sigma receptors.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>149</volume>
<fpage>171</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="pmid">2840298</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Hernandez-Lopez</surname><given-names>S.</given-names></name><name><surname>Tkatch</surname><given-names>T.</given-names></name><name><surname>Held</surname><given-names>J. E.</given-names></name><name><surname>Surmeier</surname><given-names>D. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>91</volume>
<fpage>1337</fpage>–<lpage>1349</lpage>. <pub-id pub-id-type="pmid">13679409</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shioda</surname><given-names>N.</given-names></name><name><surname>Ishikawa</surname><given-names>K.</given-names></name><name><surname>Tagashira</surname><given-names>H.</given-names></name><name><surname>Ishizuka</surname><given-names>T.</given-names></name><name><surname>Yawo</surname><given-names>H.</given-names></name><name><surname>Fukunaga</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma1 receptor, promotes mitochondrial energy depletion and apoptosis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>23318</fpage>–<lpage>23331</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.349142</pub-id>
<pub-id pub-id-type="pmid">22619170</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Mysona</surname><given-names>B. A.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Bollinger</surname><given-names>K. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Sigma 1 receptor: a novel therapeutic target in retinal disease.</article-title>
<source/><italic>Prog. Retin Eye Res.</italic>
<volume>67</volume>
<fpage>130</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2018.07.003</pub-id>
<pub-id pub-id-type="pmid">30075336</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sora</surname><given-names>I.</given-names></name><name><surname>Wichems</surname><given-names>C.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>X. F.</given-names></name><name><surname>Zeng</surname><given-names>Z.</given-names></name><name><surname>Revay</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>7699</fpage>–<lpage>7704</lpage>. <pub-id pub-id-type="pmid">9636213</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriani</surname><given-names>O.</given-names></name><name><surname>Foll</surname><given-names>F. L.</given-names></name><name><surname>Roman</surname><given-names>F.</given-names></name><name><surname>Monnet</surname><given-names>F. P.</given-names></name><name><surname>Vaudry</surname><given-names>H.</given-names></name><name><surname>Cazin</surname><given-names>L.</given-names></name></person-group> (<year>1999a</year>). <article-title>A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>289</volume>
<fpage>321</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="pmid">10087020</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriani</surname><given-names>O.</given-names></name><name><surname>Le Foll</surname><given-names>F.</given-names></name><name><surname>Galas</surname><given-names>L.</given-names></name><name><surname>Roman</surname><given-names>F.</given-names></name><name><surname>Vaudry</surname><given-names>H.</given-names></name><name><surname>Cazin</surname><given-names>L.</given-names></name></person-group> (<year>1999b</year>). <article-title>The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>277</volume>
<fpage>E73</fpage>–<lpage>E80</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.1999.277.1.E73</pub-id>
<pub-id pub-id-type="pmid">10409130</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriani</surname><given-names>O.</given-names></name><name><surname>Rapetti-Mauss</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Sigma 1 receptor and ion channel dynamics in cancer.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>964</volume>
<fpage>63</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-50174-1_6</pub-id>
<pub-id pub-id-type="pmid">28315265</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriani</surname><given-names>O.</given-names></name><name><surname>Vaudry</surname><given-names>H.</given-names></name><name><surname>Mei</surname><given-names>Y. A.</given-names></name><name><surname>Roman</surname><given-names>F.</given-names></name><name><surname>Cazin</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <article-title>Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>286</volume>
<fpage>163</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="pmid">9655856</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I.</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M.</given-names></name><name><surname>Lehmann</surname><given-names>M. H.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name><name><surname>Keating</surname><given-names>M. T.</given-names></name></person-group> (<year>1997</year>). <article-title>Mutations in the hminK gene cause long QT syndrome and suppress IKs function.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>17</volume>
<fpage>338</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="pmid">9354802</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruce</surname><given-names>B. A.</given-names></name><name><surname>Campbell</surname><given-names>L. A.</given-names></name><name><surname>McTavish</surname><given-names>N.</given-names></name><name><surname>Cooper</surname><given-names>M. A.</given-names></name><name><surname>Appleyard</surname><given-names>M. V.</given-names></name><name><surname>O’Neill</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>64</volume>
<fpage>4875</fpage>–<lpage>4886</lpage>. <pub-id pub-id-type="pmid">15256458</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strobl</surname><given-names>J. S.</given-names></name><name><surname>Wonderlin</surname><given-names>W. F.</given-names></name><name><surname>Flynn</surname><given-names>D. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Mitogenic signal transduction in human breast cancer cells.</article-title>
<source/><italic>Gen. Pharmacol. JID</italic>
<volume>7602417</volume>
<fpage>1643</fpage>–<lpage>1649</lpage>.</mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>T. P.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Maurice</surname><given-names>T.</given-names></name><name><surname>Buch</surname><given-names>S.</given-names></name><name><surname>Ruoho</surname><given-names>A. E.</given-names></name></person-group> (<year>2010</year>). <article-title>The sigma-1 receptor chaperone as an inter-organelle signaling modulator.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>31</volume>
<fpage>557</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2010.08.007</pub-id>
<pub-id pub-id-type="pmid">20869780</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>T. P.</given-names></name><name><surname>Su</surname><given-names>T. C.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Tsai</surname><given-names>S. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>The sigma-1 receptor as a pluripotent modulator in living systems.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>37</volume>
<fpage>262</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2016.01.003</pub-id>
<pub-id pub-id-type="pmid">26869505</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Maffie</surname><given-names>J. K.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Petralia</surname><given-names>R. S.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name><name><surname>Hoffman</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>DPP6 establishes the A-type K(+) current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons.</article-title>
<source/><italic>Neuron</italic>
<volume>71</volume>
<fpage>1102</fpage>–<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.08.008</pub-id>
<pub-id pub-id-type="pmid">21943606</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>A.</given-names></name><name><surname>Kovacs</surname><given-names>A.</given-names></name><name><surname>Frecska</surname><given-names>E.</given-names></name><name><surname>Rajnavolgyi</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e106533</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0106533</pub-id>
<pub-id pub-id-type="pmid">25171370</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchedre</surname><given-names>K. T.</given-names></name><name><surname>Huang</surname><given-names>R. Q.</given-names></name><name><surname>Dibas</surname><given-names>A.</given-names></name><name><surname>Krishnamoorthy</surname><given-names>R. R.</given-names></name><name><surname>Dillon</surname><given-names>G. H.</given-names></name><name><surname>Yorio</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction.</article-title>
<source/><italic>Invest. Ophthalmol. Visual Sci.</italic>
<volume>49</volume>
<fpage>4993</fpage>–<lpage>5002</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.08-1867</pub-id>
<pub-id pub-id-type="pmid">18641291</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>J. D.</given-names></name><name><surname>Longen</surname><given-names>C. G.</given-names></name><name><surname>Oyer</surname><given-names>H. M.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Maher</surname><given-names>C. M.</given-names></name><name><surname>Salvino</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Sigma1 targeting to suppress aberrant androgen receptor signaling in prostate cancer.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>77</volume>
<fpage>2439</fpage>–<lpage>2452</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-1055</pub-id>
<pub-id pub-id-type="pmid">28235766</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Kanzaki</surname><given-names>A.</given-names></name><name><surname>Okumura</surname><given-names>K.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Otsuki</surname><given-names>S.</given-names></name></person-group> (<year>1992a</year>). <article-title>Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.</article-title>
<source/><italic>Life Sci.</italic>
<volume>50</volume>
<fpage>L129</fpage>–<lpage>L134</lpage>. <pub-id pub-id-type="pmid">1313134</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Okumura</surname><given-names>K.</given-names></name><name><surname>Zushi</surname><given-names>Y.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Otsuki</surname><given-names>S.</given-names></name></person-group> (<year>1992b</year>). <article-title>Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>211</volume>
<fpage>323</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="pmid">1352252</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Tsuchida</surname><given-names>K.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Otsuki</surname><given-names>S.</given-names></name></person-group> (<year>1992c</year>). <article-title>Supersensitivity of sigma receptors after repeated administration of cocaine.</article-title>
<source/><italic>Life Sci.</italic>
<volume>51</volume>
<fpage>L31</fpage>–<lpage>L36</lpage>. <pub-id pub-id-type="pmid">1353244</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Kuroda</surname><given-names>S.</given-names></name><name><surname>Otsuki</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>sigma Receptor antagonists block the development of sensitization to cocaine.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>296</volume>
<fpage>123</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="pmid">8838447</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vacher</surname><given-names>H.</given-names></name><name><surname>Mohapatra</surname><given-names>D. P.</given-names></name><name><surname>Trimmer</surname><given-names>J. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Localization and targeting of voltage-dependent ion channels in mammalian central neurons.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>88</volume>
<fpage>1407</fpage>–<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00002.2008</pub-id>
<pub-id pub-id-type="pmid">18923186</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname><given-names>C.</given-names></name><name><surname>Barash</surname><given-names>P. G.</given-names></name><name><surname>Jatlow</surname><given-names>P.</given-names></name><name><surname>Byck</surname><given-names>R.</given-names></name></person-group> (<year>1976</year>). <article-title>Cocaine: plasma concentrations after intranasal application in man.</article-title>
<source/><italic>Science</italic>
<volume>191</volume>
<fpage>859</fpage>–<lpage>861</lpage>. <pub-id pub-id-type="pmid">56036</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenberg</surname><given-names>J. I.</given-names></name><name><surname>Perry</surname><given-names>M. D.</given-names></name><name><surname>Perrin</surname><given-names>M. J.</given-names></name><name><surname>Mann</surname><given-names>S. A.</given-names></name><name><surname>Ke</surname><given-names>Y.</given-names></name><name><surname>Hill</surname><given-names>A. P.</given-names></name></person-group> (<year>2012</year>). <article-title>hERG K(+) channels: structure, function, and clinical significance.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>92</volume>
<fpage>1393</fpage>–<lpage>1478</lpage>. <pub-id pub-id-type="pmid">22988594</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>A. W.</given-names></name><name><surname>Yuan</surname><given-names>L. L.</given-names></name><name><surname>Anderson</surname><given-names>A. E.</given-names></name><name><surname>Schrader</surname><given-names>L. A.</given-names></name><name><surname>Wu</surname><given-names>G. Y.</given-names></name><name><surname>Gatchel</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Calcium-calmodulin-dependent kinase II modulates Kv4.2 channel expression and upregulates neuronal A-type potassium currents.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>3643</fpage>–<lpage>3654</lpage>. <pub-id pub-id-type="pmid">15071113</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicini</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J. F.</given-names></name><name><surname>Li</surname><given-names>J. H.</given-names></name><name><surname>Zhu</surname><given-names>W. J.</given-names></name><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Luo</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>79</volume>
<fpage>555</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="pmid">9463421</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilner</surname><given-names>B. J.</given-names></name><name><surname>Decosta</surname><given-names>B. R.</given-names></name><name><surname>Bowen</surname><given-names>W. D.</given-names></name></person-group> (<year>1995a</year>). <article-title>Cytotoxic effects of sigma ligands: sigma receptor- mediated alterations in cellular morphology and viability.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>15</volume>
<fpage>117</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="pmid">7823122</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilner</surname><given-names>B. J.</given-names></name><name><surname>John</surname><given-names>C. S.</given-names></name><name><surname>Bowen</surname><given-names>W. D.</given-names></name></person-group> (<year>1995b</year>). <article-title>Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>55</volume>
<fpage>408</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="pmid">7812973</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>J. M.</given-names></name><name><surname>Bowen</surname><given-names>W. D.</given-names></name><name><surname>Walker</surname><given-names>F. O.</given-names></name><name><surname>Matsumoto</surname><given-names>R. R.</given-names></name><name><surname>De Costa</surname><given-names>B.</given-names></name><name><surname>Rice</surname><given-names>K. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Sigma receptors: biology and function.</article-title>
<source/><italic>Pharmacol. Rev.</italic>
<volume>42</volume>
<fpage>355</fpage>–<lpage>402</lpage>.<pub-id pub-id-type="pmid">1964225</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Otaka</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Gardner</surname><given-names>G. R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Cascades of Homeostatic dysregulation promote incubation of cocaine craving.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>38</volume>
<fpage>4316</fpage>–<lpage>4328</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3291-17.2018</pub-id>
<pub-id pub-id-type="pmid">29626166</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>H. F.</given-names></name><name><surname>Zheng</surname><given-names>L. T.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Zhen</surname><given-names>X. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Allosteric modulation of sigma-1 receptors elicits rapid antidepressant activity.</article-title>
<source/><italic>CNS Neurosci. Ther.</italic>
<volume>22</volume>
<fpage>368</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12502</pub-id>
<pub-id pub-id-type="pmid">26854125</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>T. Y.</given-names></name><name><surname>Tsai</surname><given-names>S. A.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.</article-title>
<source/><italic>J. Biomed. Sci.</italic>
<volume>24</volume>:<issue>74</issue>. <pub-id pub-id-type="doi">10.1186/s12929-017-0380-6</pub-id>
<pub-id pub-id-type="pmid">28917260</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>D. D.</given-names></name><name><surname>Edwards</surname><given-names>A. M.</given-names></name><name><surname>Ondo</surname><given-names>J. G.</given-names></name></person-group> (<year>1993</year>). <article-title>The effect of cocaine on membrane-potential, on membrane depolarization by veratridine or elevated [K]O and on sodium-potassium permeability ratios in synaptosomes from the limbic cortex of the rat.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>32</volume>
<fpage>195</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="pmid">8450944</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>F. J.</given-names></name><name><surname>Joshi</surname><given-names>A.</given-names></name><name><surname>Koeltzow</surname><given-names>T. E.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name></person-group> (<year>1998</year>). <article-title>Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>18</volume>
<fpage>26</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="pmid">9408916</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>M. E.</given-names></name></person-group> (<year>2010</year>). <article-title>The bermuda triangle of cocaine-induced neuroadaptations.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>33</volume>
<fpage>391</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2010.06.003</pub-id>
<pub-id pub-id-type="pmid">20655604</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>M. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Synaptic mechanisms underlying persistent cocaine craving.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>17</volume>
<fpage>351</fpage>–<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.39</pub-id>
<pub-id pub-id-type="pmid">27150400</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>M. E.</given-names></name><name><surname>Tseng</surname><given-names>K. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Calcium-permeable AMPA receptors in the VTA and nucleus accumbens after cocaine exposure: when, how, and why?</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>5</volume>:<issue>72</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2012.00072</pub-id>
<pub-id pub-id-type="pmid">22754497</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>A. Y.</given-names></name><name><surname>Hristova</surname><given-names>E.</given-names></name><name><surname>Ahlskog</surname><given-names>N.</given-names></name><name><surname>Tasse</surname><given-names>L. A.</given-names></name><name><surname>Ngsee</surname><given-names>J. K.</given-names></name><name><surname>Chudalayandi</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Aberrant subcellular dynamics of sigma-1 receptor mutants underlying neuromuscular diseases.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>90</volume>
<fpage>238</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1124/mol.116.104018</pub-id>
<pub-id pub-id-type="pmid">27418673</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X. Z.</given-names></name><name><surname>Bell</surname><given-names>J. A.</given-names></name><name><surname>Spivak</surname><given-names>C. E.</given-names></name><name><surname>London</surname><given-names>E. D.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>1991</year>). <article-title>Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>257</volume>
<fpage>351</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="pmid">1850471</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>H.</given-names></name><name><surname>Castle</surname><given-names>N. A.</given-names></name><name><surname>Pardo</surname><given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Voltage-gated potassium channels as therapeutic targets.</article-title>
<source/><italic>Nat. Rev. Drug Discov.</italic>
<volume>8</volume>
<fpage>982</fpage>–<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2983</pub-id>
<pub-id pub-id-type="pmid">19949402</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y. F.</given-names></name><name><surname>Ke</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>S. Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G. K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Electrophysiologic properties of lidocaine, cocaine, and n-3 fatty-acids block of cardiac Na+ channels.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>485</volume>
<fpage>31</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="pmid">14757121</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>W. D.</given-names></name><name><surname>Wu</surname><given-names>C. F.</given-names></name></person-group> (<year>2001</year>). <article-title>Distinct roles of CaMKII and PKA in regulation of firing patterns and K(+) currents in <italic>Drosophila neurons</italic>.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>85</volume>
<fpage>1384</fpage>–<lpage>1394</lpage>. <pub-id pub-id-type="pmid">11287463</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasui</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>T. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Potential molecular mechanisms on the role of the sigma-1 receptor in the action of cocaine and methamphetamine.</article-title>
<source/><italic>J. Drug Alcohol. Res.</italic>
<volume>5</volume>:<issue>235970</issue>. <pub-id pub-id-type="pmid">27088037</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Cuevas</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>87</volume>
<fpage>2867</fpage>–<lpage>2879</lpage>. <pub-id pub-id-type="pmid">12037190</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Cuevas</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>sigma receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>313</volume>
<fpage>1387</fpage>–<lpage>1396</lpage>. <pub-id pub-id-type="pmid">15764734</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Katnik</surname><given-names>C.</given-names></name><name><surname>Cuevas</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons.</article-title>
<source/><italic>Int. J. Physiol. Pathophysiol. Pharmacol.</italic>
<volume>2</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="pmid">21383893</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X. F.</given-names></name><name><surname>Cooper</surname><given-names>D. C.</given-names></name><name><surname>White</surname><given-names>F. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>301</volume>
<fpage>1119</fpage>–<lpage>1125</lpage>. <pub-id pub-id-type="pmid">12023545</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X. F.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name><name><surname>White</surname><given-names>F. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>18</volume>
<fpage>488</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="pmid">9412525</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimanyi</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Lajtha</surname><given-names>A.</given-names></name><name><surname>Reith</surname><given-names>M. E. A.</given-names></name></person-group> (<year>1989</year>). <article-title>Effect of cocaine and cocaine congeners on veratridine-induced depolarization in mouse cerebrocortical synaptoneurosomes.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>22</volume>
<fpage>201</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="pmid">2540338</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>